Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT01126437
First received: May 6, 2010
Last updated: May 20, 2014
Last verified: May 2014
  Purpose

Direct comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations have been limited to 4-week crossover studies. Therefore, prospective data from a trial of adequate size and duration is required to establish that compared to tiotropium HandiHaler®, tiotropium Respimat® will have (a) similar effects on safety and (b) similar or superior effects on exacerbations.


Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive
Drug: tiotropium 18 mcg
Drug: tiotropium 1.25 mcg (2 actuations/day)
Drug: tiotropium 2.5 mcg (2 actuations/day)
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Design, Multi-center Trial to Compare the Efficacy and Safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution Delivered by the Respimat Inhaler With Tiotropium Inhalation Capsules 18 µg Delivered by the HandiHaler (TIOSPIR)

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • Time to All-Cause Mortality [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    Number of patients with all-cause mortality

  • Time to First COPD Exacerbation [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]

    Defined as "a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment" where a "complex of lower respiratory event/symptoms" was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where "a required change in treatment" includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).

    "Onset of exacerbation" was defined by the onset of first recorded symptom. The "end of exacerbation" was decided by the investigator based on clinical judgement.

    Exacerbations were classified as follows:

    Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.



Secondary Outcome Measures:
  • Trough FEV1 Over 120 Weeks (in a Substudy of 1370 Patients) [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    Trough forced expiratory volume in one second (FEV1) over 120 weeks (in a substudy of 1370 patients)

  • Number of COPD Exacerbations [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    The number of COPD exacerbations. COPD exacerbation defined as "a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment" where a "complex of lower respiratory event/symptoms" was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where "a required change in treatment" includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).

  • Time to First Hospitalization Associated With COPD Exacerbation [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    The results presented below are for the patients with hospitalizations due to COPD exacerbations.

  • Number of Hospitalizations Associated With COPD Exacerbation [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    Total number of hospitalizations associated with COPD exacerbation.

  • Time to First Moderate to Severe COPD Exacerbation [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]

    COPD exacerbation defined as "a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment" where a "complex of lower respiratory event/symptoms" was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where "a required change in treatment" includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).

    Exacerbations classified as follows:

    Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.

    Results presented below are number of patients with moderate to severe exacerbations.


  • Time to Onset of First Major Adverse Cardiovascular Event (MACE) [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    Time to onset of first major adverse cardiovascular event (MACE). MACE was defined as: Fatal event in the system organ classes of cardiac and vascular disorders, Preferred terms: sudden death, cardiac death, sudden cardiac death, Outcome events of myocardial infarction (serious and non-serious), Outcome events of stroke (serious and non-serious) and Outcome events of TIA (serious and non-serious). The results presented below are for the number of patients with MACE.

  • Time to Death From Major Adverse Cardiovascular Event (MACE) [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    The results presented below are number of patients with death from MACE.


Enrollment: 17183
Study Start Date: May 2010
Study Completion Date: May 2013
Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: tiotropium 2.5 mcg and placebo
Patients receive one of the active tiotropium arms daily
Drug: tiotropium 1.25 mcg (2 actuations/day)
soft mist inhaler 2 actuations=2 puffs/day
Active Comparator: tiotropium 18 mcg and placebo
Patients receive one of the active tiotropium arms daily
Drug: tiotropium 18 mcg
HandiHaler
Experimental: tiotropium 5 mcg and placebo
Patients receive one of the active tiotropium arms daily
Drug: tiotropium 2.5 mcg (2 actuations/day)
soft mist inhaler (2 actuations=2 puffs/day)

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  1. All patients must sign an informed consent consistent with International Conference on Harmonization Good Clinical Practice (ICH-GCP) guidelines prior to participation in the trial, which includes medication washout and restrictions.
  2. Male or female patients 40 years of age or older.
  3. Patients must be current or ex-smokers with a smoking history of ≥10 pack-years. (Patients who have never smoked cigarettes must be excluded)
  4. All patients must have a diagnosis of COPD (P06-12085), and must meet the following criteria: Relatively stable airway obstruction with a post-bronchodilator FEV1 ≤ 70% of predicted normal and post-bronchodilator FEV1 / FVC ≤70%.

    Pulmonary function tests (PFTs) were conducted after the inhalation of 400 μg salbutamol / albuterol (preferred), however testing with either 200 μg salbutamol/albuterol or a combination of salbutamol / albuterol with ipratropium bromide (2 to 4 actuations) was acceptable. Other short-acting beta agonists, such as terbutaline, may have been used for the testing. The medication used for the testing was documented. Further, historical data from measurements within the past 6 months either at the site or at a referral site may have been used (see Section 6.2.1 of the CTP, located in Appendix 16.1.1). Subjects were not to have been randomized to the study without the availability of spirometry data at the actual study site.

    Eligibility for PFT sub-study: For subjects participating in the spirometry sub-study, historical data may not have been used for inclusion. These subjects must have qualified in the clinic at Visit 1 after performing a baseline measurement. These subjects performed a pre-dose PFT which was followed by the administration of 400 μg salbutamol / albuterol only (no other short-acting beta agonist was allowed), followed by a post-dose PFT for qualification.

  5. Able to inhale from the HandiHaler® and the Respimat® devices.

Exclusion criteria:

  1. Significant diseases other than COPD. A significant disease is defined as a disease or condition which, in the opinion of the investigator, may put the patient at risk because of participation in the study or may influence the patients ability to participate in the study.
  2. Patients with a recent history (i.e., six months or less) of myocardial infarction.
  3. Patients with any unstable or life-threatening cardiac arrhythmia requiring intervention or change in drug therapy during the last year.
  4. Hospitalisation for cardiac failure (New York Heart Association (NYHA) Class III or IV) during the past year.
  5. Known active tuberculosis.
  6. Patients with a history of asthma, cystic fibrosis, clinically evident bronchiectasis, interstitial lung disease, or pulmonary thromboembolic disease.
  7. History of thoracotomy with pulmonary resection. Subjects with a history of thoracotomy for other reasons were to have been evaluated per exclusion criterion 1.
  8. Subject was planning to undergo lung transplant or lung volume reduction surgery (LVRS).
  9. Malignancy for which the subject had undergone resection, radiation, chemotherapy or biological treatments within the last 5 years. Subjects with treated basal cell carcinoma were allowed.
  10. Known respiratory infection or exacerbation of COPD in the 4 weeks prior to randomization.
  11. Known hypersensitivity to anticholinergic drugs, lactose, benzalkonium chloride (BAC), ethylenediaminetetraacetic acid (EDTA), or any other components of the HandiHaler® or Respimat® inhalation solution delivery system.
  12. Known moderate to severe renal impairment (as judged by the investigator).
  13. Known narrow angle glaucoma.
  14. Known significant symptomatic prostatic hyperplasia or bladder-neck obstruction. Subjects whose symptoms were controlled on treatment may have been included.
  15. Use of systemic corticosteroid medication at unstable doses (i.e., less than 6 weeks on stable dose) or at doses in excess of the equivalent of 10 mg prednisolone per day.
  16. Pregnant or nursing women or women of childbearing potential not using a medically approved means of contraception for at least 3 months prior to and for the duration of the trial.
  17. Significant alcohol or drug abuse within the past 12 months.
  18. Subjects requiring the use of supplemental oxygen therapy for > 12 hours per day.
  19. Subjects who had completed a pulmonary rehabilitation program in the 6 weeks prior to the screening visit or subjects who were currently in a pulmonary rehabilitation program that was not maintained throughout the duration of the study.
  20. Subjects who had taken an investigational drug within 30 days prior to the Screening Visit.
  21. Previous participation (receipt of randomized treatment) in this study.
  22. Subjects who were currently participating in an interventional study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01126437

  Hide Study Locations
Locations
United States, Alabama
205.452.01107 Boehringer Ingelheim Investigational Site
Athens, Alabama, United States
205.452.01023 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
205.452.01035 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
205.452.01280 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
205.452.01052 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
205.452.01227 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
205.452.01219 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
205.452.01198 Boehringer Ingelheim Investigational Site
Florence, Alabama, United States
205.452.01244 Boehringer Ingelheim Investigational Site
Mobile, Alabama, United States
205.452.01041 Boehringer Ingelheim Investigational Site
Montgomery, Alabama, United States
United States, Alaska
205.452.01070 Boehringer Ingelheim Investigational Site
Anchorage, Alaska, United States
United States, Arizona
205.452.01218 Boehringer Ingelheim Investigational Site
Chandler, Arizona, United States
205.452.01317 Boehringer Ingelheim Investigational Site
Mesa, Arizona, United States
205.452.01175 Boehringer Ingelheim Investigational Site
Mesa, Arizona, United States
205.452.01200 Boehringer Ingelheim Investigational Site
Mesa, Arizona, United States
205.452.01350 Boehringer Ingelheim Investigational Site
Pheonix, Arizona, United States
205.452.01254 Boehringer Ingelheim Investigational Site
Phoenix, Arizona, United States
205.452.01283 Boehringer Ingelheim Investigational Site
Phoenix, Arizona, United States
205.452.01315 Boehringer Ingelheim Investigational Site
Tempe, Arizona, United States
205.452.01161 Boehringer Ingelheim Investigational Site
Tucson, Arizona, United States
205.452.01158 Boehringer Ingelheim Investigational Site
Tucson, Arizona, United States
United States, California
205.452.01302 Boehringer Ingelheim Investigational Site
Anaheim, California, United States
205.452.01038 Boehringer Ingelheim Investigational Site
Encinitas, California, United States
205.452.01313 Boehringer Ingelheim Investigational Site
Fountain Valley, California, United States
205.452.01375 Boehringer Ingelheim Investigational Site
Fountain Valley, California, United States
205.452.01074 Boehringer Ingelheim Investigational Site
Fullerton, California, United States
205.452.01345 Boehringer Ingelheim Investigational Site
Lancaster, California, United States
205.452.01171 Boehringer Ingelheim Investigational Site
Lincoln, California, United States
205.452.01339 Boehringer Ingelheim Investigational Site
Lomita, California, United States
205.452.01356 Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
205.452.01298 Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
205.452.01148 Boehringer Ingelheim Investigational Site
Orange, California, United States
205.452.01111 Boehringer Ingelheim Investigational Site
Palm Springs, California, United States
205.452.01147 Boehringer Ingelheim Investigational Site
Paramount, California, United States
205.452.01071 Boehringer Ingelheim Investigational Site
Poway, California, United States
205.452.01089 Boehringer Ingelheim Investigational Site
Rancho Cucamonga, California, United States
205.452.01097 Boehringer Ingelheim Investigational Site
Redlands, California, United States
205.452.01176 Boehringer Ingelheim Investigational Site
San Diego, California, United States
205.452.01346 Boehringer Ingelheim Investigational Site
San Diego, California, United States
205.452.01078 Boehringer Ingelheim Investigational Site
San Diego, California, United States
205.452.01306 Boehringer Ingelheim Investigational Site
San Jose, California, United States
205.452.01297 Boehringer Ingelheim Investigational Site
Santa Barbara, California, United States
205.452.01362 Boehringer Ingelheim Investigational Site
Tustin, California, United States
205.452.01225 Boehringer Ingelheim Investigational Site
Victorville, California, United States
205.452.01224 Boehringer Ingelheim Investigational Site
Walnut Creek, California, United States
205.452.01236 Boehringer Ingelheim Investigational Site
Wildomar, California, United States
United States, Colorado
205.452.01245 Boehringer Ingelheim Investigational Site
Colorado Springs, Colorado, United States
205.452.01049 Boehringer Ingelheim Investigational Site
Colorado Springs, Colorado, United States
205.452.01351 Boehringer Ingelheim Investigational Site
Denver, Colorado, United States
205.452.01018 Boehringer Ingelheim Investigational Site
Fort Collins, Colorado, United States
205.452.01024 Boehringer Ingelheim Investigational Site
Wheat Ridge, Colorado, United States
205.452.01005 Boehringer Ingelheim Investigational Site
Wheat Ridge, Colorado, United States
United States, Connecticut
205.452.01199 Boehringer Ingelheim Investigational Site
Danbury, Connecticut, United States
205.452.01054 Boehringer Ingelheim Investigational Site
Hartford, Connecticut, United States
205.452.01072 Boehringer Ingelheim Investigational Site
Norwalk, Connecticut, United States
205.452.01040 Boehringer Ingelheim Investigational Site
Stamford, Connecticut, United States
205.452.01109 Boehringer Ingelheim Investigational Site
Waterbury, Connecticut, United States
United States, Delaware
205.452.01308 Boehringer Ingelheim Investigational Site
Newark, Delaware, United States
United States, Florida
205.452.01011 Boehringer Ingelheim Investigational Site
Clearwater, Florida, United States
205.452.01209 Boehringer Ingelheim Investigational Site
Hialeah, Florida, United States
205.452.01360 Boehringer Ingelheim Investigational Site
Homestead, Florida, United States
205.452.01241 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
205.452.01343 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
205.452.01337 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
205.452.01184 Boehringer Ingelheim Investigational Site
Jupiter, Florida, United States
205.452.01321 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
205.452.01138 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
205.452.01246 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
205.452.01290 Boehringer Ingelheim Investigational Site
New Port Richey, Florida, United States
205.452.01203 Boehringer Ingelheim Investigational Site
Ocala, Florida, United States
205.452.01174 Boehringer Ingelheim Investigational Site
Orlando, Florida, United States
205.452.01135 Boehringer Ingelheim Investigational Site
Ormond Beach, Florida, United States
205.452.01173 Boehringer Ingelheim Investigational Site
Oviedo, Florida, United States
205.452.01197 Boehringer Ingelheim Investigational Site
Panama City, Florida, United States
205.452.01195 Boehringer Ingelheim Investigational Site
Panama City, Florida, United States
205.452.01239 Boehringer Ingelheim Investigational Site
Pembroke Pines, Florida, United States
205.452.01286 Boehringer Ingelheim Investigational Site
Pembroke Pines, Florida, United States
205.452.01247 Boehringer Ingelheim Investigational Site
Pembroke Pines, Florida, United States
205.452.01240 Boehringer Ingelheim Investigational Site
Pensacola, Florida, United States
205.452.01260 Boehringer Ingelheim Investigational Site
Ponte Vedra, Florida, United States
205.452.01092 Boehringer Ingelheim Investigational Site
Rockledge, Florida, United States
205.452.01251 Boehringer Ingelheim Investigational Site
Sarasota, Florida, United States
205.452.01207 Boehringer Ingelheim Investigational Site
St. Petersburg, Florida, United States
205.452.01133 Boehringer Ingelheim Investigational Site
St. Petersburg, Florida, United States
205.452.01136 Boehringer Ingelheim Investigational Site
St. Petersburg, Florida, United States
205.452.01231 Boehringer Ingelheim Investigational Site
Tamarac, Florida, United States
205.452.01134 Boehringer Ingelheim Investigational Site
Tamarac, Florida, United States
205.452.01250 Boehringer Ingelheim Investigational Site
Tampa, Florida, United States
205.452.01025 Boehringer Ingelheim Investigational Site
Tampa, Florida, United States
205.452.01060 Boehringer Ingelheim Investigational Site
Winter Park, Florida, United States
United States, Georgia
205.452.01130 Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
205.452.01047 Boehringer Ingelheim Investigational Site
Austell, Georgia, United States
205.452.01255 Boehringer Ingelheim Investigational Site
Columbus, Georgia, United States
205.452.01012 Boehringer Ingelheim Investigational Site
Conyers, Georgia, United States
205.452.01299 Boehringer Ingelheim Investigational Site
Gainesville, Georgia, United States
205.452.01288 Boehringer Ingelheim Investigational Site
Lawrenceville, Georgia, United States
205.452.01090 Boehringer Ingelheim Investigational Site
Snellville, Georgia, United States
United States, Hawaii
205.452.01100 Boehringer Ingelheim Investigational Site
Honolulu, Hawaii, United States
United States, Idaho
205.452.01165 Boehringer Ingelheim Investigational Site
Boise, Idaho, United States
205.452.01059 Boehringer Ingelheim Investigational Site
Coeur d'Alene, Idaho, United States
205.452.01062 Boehringer Ingelheim Investigational Site
Eagle, Idaho, United States
205.452.01166 Boehringer Ingelheim Investigational Site
Hayden Lake, Idaho, United States
205.452.01275 Boehringer Ingelheim Investigational Site
Meridian, Idaho, United States
United States, Illinois
205.452.01330 Boehringer Ingelheim Investigational Site
Arlington Heights, Illinois, United States
205.452.01248 Boehringer Ingelheim Investigational Site
Belleville, Illinois, United States
205.452.01278 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
205.452.01371 Boehringer Ingelheim Investigational Site
Downer Grove, Illinois, United States
205.452.01235 Boehringer Ingelheim Investigational Site
Lombard, Illinois, United States
205.452.01180 Boehringer Ingelheim Investigational Site
O'Fallon, Illinois, United States
205.452.01268 Boehringer Ingelheim Investigational Site
Oak Park, Illinois, United States
205.452.01359 Boehringer Ingelheim Investigational Site
Quincy, Illinois, United States
United States, Indiana
205.452.01347 Boehringer Ingelheim Investigational Site
Brownsburg, Indiana, United States
205.452.01153 Boehringer Ingelheim Investigational Site
Evansville, Indiana, United States
205.452.01301 Boehringer Ingelheim Investigational Site
Fishers, Indiana, United States
205.452.01141 Boehringer Ingelheim Investigational Site
Franklin, Indiana, United States
205.452.01137 Boehringer Ingelheim Investigational Site
Lafayette, Indiana, United States
205.452.01263 Boehringer Ingelheim Investigational Site
Muncie, Indiana, United States
United States, Iowa
205.452.01284 Boehringer Ingelheim Investigational Site
Council Bluffs, Iowa, United States
205.452.01021 Boehringer Ingelheim Investigational Site
Dubuque, Iowa, United States
United States, Kansas
205.452.01305 Boehringer Ingelheim Investigational Site
Lansing, Kansas, United States
205.452.01304 Boehringer Ingelheim Investigational Site
Olathe, Kansas, United States
205.452.01125 Boehringer Ingelheim Investigational Site
Overland Park, Kansas, United States
205.452.01068 Boehringer Ingelheim Investigational Site
Topeka, Kansas, United States
United States, Kentucky
205.452.01063 Boehringer Ingelheim Investigational Site
Bowling Green, Kentucky, United States
205.452.01206 Boehringer Ingelheim Investigational Site
Fort Mitchell, Kentucky, United States
205.452.01289 Boehringer Ingelheim Investigational Site
Louisville, Kentucky, United States
205.452.01152 Boehringer Ingelheim Investigational Site
Paducah, Kentucky, United States
United States, Louisiana
205.452.01015 Boehringer Ingelheim Investigational Site
Lafayette, Louisiana, United States
205.452.01091 Boehringer Ingelheim Investigational Site
Shreveport, Louisiana, United States
205.452.01329 Boehringer Ingelheim Investigational Site
Shreveport, Louisiana, United States
United States, Maine
205.452.01364 Boehringer Ingelheim Investigational Site
Auburn, Maine, United States
205.452.01169 Boehringer Ingelheim Investigational Site
Bangor, Maine, United States
205.452.01022 Boehringer Ingelheim Investigational Site
Biddeford, Maine, United States
United States, Maryland
205.452.01053 Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
205.452.01190 Boehringer Ingelheim Investigational Site
Elkridge, Maryland, United States
205.452.01336 Boehringer Ingelheim Investigational Site
Hollywood, Maryland, United States
205.452.01243 Boehringer Ingelheim Investigational Site
Towson, Maryland, United States
205.452.01238 Boehringer Ingelheim Investigational Site
Towson, Maryland, United States
United States, Massachusetts
205.452.01366 Boehringer Ingelheim Investigational Site
Fall River, Massachusetts, United States
205.452.01269 Boehringer Ingelheim Investigational Site
Haverhill, Massachusetts, United States
205.452.01208 Boehringer Ingelheim Investigational Site
New Bedford, Massachusetts, United States
205.452.01170 Boehringer Ingelheim Investigational Site
Worcester, Massachusetts, United States
United States, Michigan
205.452.01270 Boehringer Ingelheim Investigational Site
Ann Arbor, Michigan, United States
205.452.01349 Boehringer Ingelheim Investigational Site
Benzonia, Michigan, United States
205.452.01365 Boehringer Ingelheim Investigational Site
Chelsea, Michigan, United States
205.452.01149 Boehringer Ingelheim Investigational Site
Chesterfield, Michigan, United States
205.452.01146 Boehringer Ingelheim Investigational Site
Detroit, Michigan, United States
205.452.01139 Boehringer Ingelheim Investigational Site
Interlochen, Michigan, United States
205.452.01080 Boehringer Ingelheim Investigational Site
Kalamazoo, Michigan, United States
205.452.01310 Boehringer Ingelheim Investigational Site
Stevensville, Michigan, United States
205.452.01122 Boehringer Ingelheim Investigational Site
Traverse City, Michigan, United States
205.452.01221 Boehringer Ingelheim Investigational Site
Troy, Michigan, United States
205.452.01081 Boehringer Ingelheim Investigational Site
Troy, Michigan, United States
United States, Minnesota
205.452.01205 Boehringer Ingelheim Investigational Site
Chaska, Minnesota, United States
205.452.01211 Boehringer Ingelheim Investigational Site
Edina, Minnesota, United States
205.452.01104 Boehringer Ingelheim Investigational Site
Fridley, Minnesota, United States
205.452.01113 Boehringer Ingelheim Investigational Site
Minneapolis, Minnesota, United States
205.452.01042 Boehringer Ingelheim Investigational Site
Rochester, Minnesota, United States
United States, Mississippi
205.452.01019 Boehringer Ingelheim Investigational Site
Olive Branch, Mississippi, United States
United States, Missouri
205.452.01014 Boehringer Ingelheim Investigational Site
Chesterfield, Missouri, United States
205.452.01129 Boehringer Ingelheim Investigational Site
St. Charles, Missouri, United States
205.452.01110 Boehringer Ingelheim Investigational Site
St. Louis, Missouri, United States
205.452.01179 Boehringer Ingelheim Investigational Site
West Plains, Missouri, United States
United States, Montana
205.452.01226 Boehringer Ingelheim Investigational Site
Billings, Montana, United States
205.452.01076 Boehringer Ingelheim Investigational Site
Butte, Montana, United States
205.452.01196 Boehringer Ingelheim Investigational Site
Missoula, Montana, United States
United States, Nebraska
205.452.01150 Boehringer Ingelheim Investigational Site
Bellevue, Nebraska, United States
205.452.01187 Boehringer Ingelheim Investigational Site
Fremont, Nebraska, United States
205.452.01155 Boehringer Ingelheim Investigational Site
Omaha, Nebraska, United States
United States, Nevada
205.452.01073 Boehringer Ingelheim Investigational Site
Henderson, Nevada, United States
205.452.01261 Boehringer Ingelheim Investigational Site
Las Vegas, Nevada, United States
205.452.01031 Boehringer Ingelheim Investigational Site
Las Vegas, Nevada, United States
United States, New Hampshire
205.452.01026 Boehringer Ingelheim Investigational Site
Lebanon, New Hampshire, United States
205.452.01369 Boehringer Ingelheim Investigational Site
Newington, New Hampshire, United States
United States, New Jersey
205.452.01296 Boehringer Ingelheim Investigational Site
Ocean, New Jersey, United States
205.452.01046 Boehringer Ingelheim Investigational Site
Toms River, New Jersey, United States
United States, New Mexico
205.452.01061 Boehringer Ingelheim Investigational Site
Albuquerque, New Mexico, United States
205.452.01167 Boehringer Ingelheim Investigational Site
Albuquerque, New Mexico, United States
United States, New York
205.452.01159 Boehringer Ingelheim Investigational Site
Bayside, New York, United States
205.452.01163 Boehringer Ingelheim Investigational Site
Bronxville, New York, United States
205.452.01194 Boehringer Ingelheim Investigational Site
Cooperstown, New York, United States
205.452.01131 Boehringer Ingelheim Investigational Site
Elmira, New York, United States
205.452.01142 Boehringer Ingelheim Investigational Site
Endwell, New York, United States
205.452.01192 Boehringer Ingelheim Investigational Site
Glens Falls, New York, United States
205.452.01279 Boehringer Ingelheim Investigational Site
Great Neck, New York, United States
205.452.01328 Boehringer Ingelheim Investigational Site
Honeoye Falls, New York, United States
205.452.01118 Boehringer Ingelheim Investigational Site
New Windsor, New York, United States
205.452.01127 Boehringer Ingelheim Investigational Site
New York, New York, United States
205.452.01058 Boehringer Ingelheim Investigational Site
Rochester, New York, United States
205.452.01293 Boehringer Ingelheim Investigational Site
Syracuse, New York, United States
205.452.01085 Boehringer Ingelheim Investigational Site
Syracuse, New York, United States
205.452.01151 Boehringer Ingelheim Investigational Site
Vestal, New York, United States
205.452.01188 Boehringer Ingelheim Investigational Site
Westfield, New York, United States
United States, North Carolina
205.452.01271 Boehringer Ingelheim Investigational Site
Asheville, North Carolina, United States
205.452.01101 Boehringer Ingelheim Investigational Site
Burlington, North Carolina, United States
205.452.01264 Boehringer Ingelheim Investigational Site
Calabash, North Carolina, United States
205.452.01168 Boehringer Ingelheim Investigational Site
Charlotte, North Carolina, United States
205.452.01108 Boehringer Ingelheim Investigational Site
Elizabeth City, North Carolina, United States
205.452.01172 Boehringer Ingelheim Investigational Site
Greensboro, North Carolina, United States
205.452.01033 Boehringer Ingelheim Investigational Site
Greensboro, North Carolina, United States
205.452.01098 Boehringer Ingelheim Investigational Site
Hickory, North Carolina, United States
205.452.01115 Boehringer Ingelheim Investigational Site
Hickory, North Carolina, United States
205.452.01128 Boehringer Ingelheim Investigational Site
Raleigh, North Carolina, United States
205.452.01352 Boehringer Ingelheim Investigational Site
Rocky Mount, North Carolina, United States
205.452.01348 Boehringer Ingelheim Investigational Site
Salisbury, North Carolina, United States
205.452.01032 Boehringer Ingelheim Investigational Site
Statesville, North Carolina, United States
205.452.01276 Boehringer Ingelheim Investigational Site
Tabor City, North Carolina, United States
205.452.01157 Boehringer Ingelheim Investigational Site
Wilmington, North Carolina, United States
205.452.01363 Boehringer Ingelheim Investigational Site
Winston Salem, North Carolina, United States
United States, Ohio
205.452.01193 Boehringer Ingelheim Investigational Site
Canal Fulton, Ohio, United States
205.452.01374 Boehringer Ingelheim Investigational Site
Centerville, Ohio, United States
205.452.01006 Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
205.452.01373 Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
205.452.01314 Boehringer Ingelheim Investigational Site
Cleveland, Ohio, United States
205.452.01210 Boehringer Ingelheim Investigational Site
Columbus, Ohio, United States
205.452.01232 Boehringer Ingelheim Investigational Site
Columbus, Ohio, United States
205.452.01309 Boehringer Ingelheim Investigational Site
Dayton, Ohio, United States
205.452.01140 Boehringer Ingelheim Investigational Site
Delaware, Ohio, United States
205.452.01084 Boehringer Ingelheim Investigational Site
Sylvania, Ohio, United States
205.452.01287 Boehringer Ingelheim Investigational Site
Toledo, Ohio, United States
United States, Oklahoma
205.452.01010 Boehringer Ingelheim Investigational Site
Oklahoma City, Oklahoma, United States
205.452.01094 Boehringer Ingelheim Investigational Site
Oklahoma City, Oklahoma, United States
205.452.01029 Boehringer Ingelheim Investigational Site
Tulsa, Oklahoma, United States
205.452.01043 Boehringer Ingelheim Investigational Site
Tulsa, Oklahoma, United States
United States, Oregon
205.452.01266 Boehringer Ingelheim Investigational Site
Ashland, Oregon, United States
205.452.01083 Boehringer Ingelheim Investigational Site
Bend, Oregon, United States
205.452.01189 Boehringer Ingelheim Investigational Site
Corvallis, Oregon, United States
205.452.01341 Boehringer Ingelheim Investigational Site
Springfield, Oregon, United States
United States, Pennsylvania
205.452.01002 Boehringer Ingelheim Investigational Site
Altoona, Pennsylvania, United States
205.452.01354 Boehringer Ingelheim Investigational Site
Beaver, Pennsylvania, United States
205.452.01143 Boehringer Ingelheim Investigational Site
Carnegie, Pennsylvania, United States
205.452.01320 Boehringer Ingelheim Investigational Site
Downingtown, Pennsylvania, United States
205.452.01323 Boehringer Ingelheim Investigational Site
Erie, Pennsylvania, United States
205.452.01257 Boehringer Ingelheim Investigational Site
Jefferson Hills, Pennsylvania, United States
205.452.01332 Boehringer Ingelheim Investigational Site
Langhorne, Pennsylvania, United States
205.452.01075 Boehringer Ingelheim Investigational Site
Norristown, Pennsylvania, United States
205.452.01144 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
205.452.01087 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
205.452.01361 Boehringer Ingelheim Investigational Site
Pittsburgh, Pennsylvania, United States
205.452.01003 Boehringer Ingelheim Investigational Site
Pittsburgh, Pennsylvania, United States
205.452.01036 Boehringer Ingelheim Investigational Site
Pleasant Hills, Pennsylvania, United States
205.452.01156 Boehringer Ingelheim Investigational Site
Uniontown, Pennsylvania, United States
205.452.01106 Boehringer Ingelheim Investigational Site
Uniontown, Pennsylvania, United States
205.452.01204 Boehringer Ingelheim Investigational Site
Warminster, Pennsylvania, United States
205.452.01338 Boehringer Ingelheim Investigational Site
Wyomissing, Pennsylvania, United States
United States, Rhode Island
205.452.01267 Boehringer Ingelheim Investigational Site
Cranston, Rhode Island, United States
205.452.01214 Boehringer Ingelheim Investigational Site
Johnston, Rhode Island, United States
United States, South Carolina
205.452.01340 Boehringer Ingelheim Investigational Site
Anderson, South Carolina, United States
205.452.01066 Boehringer Ingelheim Investigational Site
Charleston, South Carolina, United States
205.452.01217 Boehringer Ingelheim Investigational Site
Columbia, South Carolina, United States
205.452.01303 Boehringer Ingelheim Investigational Site
Easley, South Carolina, United States
205.452.01259 Boehringer Ingelheim Investigational Site
Florence, South Carolina, United States
205.452.01013 Boehringer Ingelheim Investigational Site
Gaffney, South Carolina, United States
205.452.01077 Boehringer Ingelheim Investigational Site
Greenville, South Carolina, United States
205.452.01093 Boehringer Ingelheim Investigational Site
Greer, South Carolina, United States
205.452.01295 Boehringer Ingelheim Investigational Site
Hodges, South Carolina, United States
205.452.01335 Boehringer Ingelheim Investigational Site
Myrtle Beach, South Carolina, United States
205.452.01056 Boehringer Ingelheim Investigational Site
Rock Hill, South Carolina, United States
205.452.01294 Boehringer Ingelheim Investigational Site
Spartanburg, South Carolina, United States
United States, South Dakota
205.452.01004 Boehringer Ingelheim Investigational Site
Rapid City, South Dakota, United States
United States, Tennessee
205.452.01126 Boehringer Ingelheim Investigational Site
Brentwood, Tennessee, United States
205.452.01220 Boehringer Ingelheim Investigational Site
Chattanooga, Tennessee, United States
205.452.01324 Boehringer Ingelheim Investigational Site
Chattanooga, Tennessee, United States
205.452.01342 Boehringer Ingelheim Investigational Site
Kingsport, Tennessee, United States
United States, Texas
205.452.01096 Boehringer Ingelheim Investigational Site
Arlington, Texas, United States
205.452.01050 Boehringer Ingelheim Investigational Site
Corsicana, Texas, United States
205.452.01334 Boehringer Ingelheim Investigational Site
Dallas, Texas, United States
205.452.01233 Boehringer Ingelheim Investigational Site
Dallas, Texas, United States
205.452.01057 Boehringer Ingelheim Investigational Site
Fort Worth, Texas, United States
205.452.01181 Boehringer Ingelheim Investigational Site
Fort Worth, Texas, United States
205.452.01272 Boehringer Ingelheim Investigational Site
Fort Worth, Texas, United States
205.452.01105 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
205.452.01212 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
205.452.01178 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
205.452.01082 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
205.452.01274 Boehringer Ingelheim Investigational Site
Longview, Texas, United States
205.452.01116 Boehringer Ingelheim Investigational Site
McKinney, Texas, United States
205.452.01262 Boehringer Ingelheim Investigational Site
Richardson, Texas, United States
205.452.01353 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
205.452.01182 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
205.452.01186 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
205.452.01055 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
205.452.01215 Boehringer Ingelheim Investigational Site
Sugar Land, Texas, United States
United States, Utah
205.452.01223 Boehringer Ingelheim Investigational Site
Midvale, Utah, United States
205.452.01001 Boehringer Ingelheim Investigational Site
Salt Lake City, Utah, United States
United States, Virginia
205.452.01079 Boehringer Ingelheim Investigational Site
Abingdon, Virginia, United States
205.452.01234 Boehringer Ingelheim Investigational Site
Alexandria, Virginia, United States
205.452.01065 Boehringer Ingelheim Investigational Site
Danville, Virginia, United States
205.452.01285 Boehringer Ingelheim Investigational Site
Danville, Virginia, United States
205.452.01045 Boehringer Ingelheim Investigational Site
Ettrick, Virginia, United States
205.452.01030 Boehringer Ingelheim Investigational Site
Lynchburg, Virginia, United States
205.452.01044 Boehringer Ingelheim Investigational Site
Richmond, Virginia, United States
205.452.01016 Boehringer Ingelheim Investigational Site
Richmond, Virginia, United States
205.452.01300 Boehringer Ingelheim Investigational Site
Richmond, Virginia, United States
205.452.01039 Boehringer Ingelheim Investigational Site
Richmond, Virginia, United States
United States, Washington
205.452.01099 Boehringer Ingelheim Investigational Site
Selah, Washington, United States
205.452.01069 Boehringer Ingelheim Investigational Site
Spokane, Washington, United States
205.452.01145 Boehringer Ingelheim Investigational Site
Spokane, Washington, United States
205.452.01008 Boehringer Ingelheim Investigational Site
Spokane, Washington, United States
205.452.01185 Boehringer Ingelheim Investigational Site
Tacoma, Washington, United States
205.452.01007 Boehringer Ingelheim Investigational Site
Wenatchee, Washington, United States
United States, Wisconsin
205.452.01201 Boehringer Ingelheim Investigational Site
Oregon, Wisconsin, United States
205.452.01344 Boehringer Ingelheim Investigational Site
West Allis, Wisconsin, United States
Argentina
205.452.54027 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
205.452.54031 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
205.452.54029 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
205.452.54003 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
205.452.54013 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
205.452.54011 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
205.452.54025 Boehringer Ingelheim Investigational Site
Florencio Varela, Argentina
205.452.54007 Boehringer Ingelheim Investigational Site
Mar del Plata, Argentina
205.452.54015 Boehringer Ingelheim Investigational Site
Mar del Plata, Argentina
205.452.54001 Boehringer Ingelheim Investigational Site
Mendoza, Argentina
205.452.54019 Boehringer Ingelheim Investigational Site
Monte Grande, Argentina
205.452.54005 Boehringer Ingelheim Investigational Site
Quilmes, Argentina
205.452.54009 Boehringer Ingelheim Investigational Site
Rosario, Argentina
205.452.54021 Boehringer Ingelheim Investigational Site
Rosario, Argentina
205.452.54023 Boehringer Ingelheim Investigational Site
San Miguel de Tucumán, Argentina
205.452.54017 Boehringer Ingelheim Investigational Site
San Miguel de Tucumán, Argentina
Australia, South Australia
205.452.61006 Boehringer Ingelheim Investigational Site
Adelaide, South Australia, Australia
205.452.61002 Boehringer Ingelheim Investigational Site
Woodville, South Australia, Australia
Australia, Victoria
205.452.61004 Boehringer Ingelheim Investigational Site
Box Hill, Victoria, Australia
205.452.61003 Boehringer Ingelheim Investigational Site
Footscray, Victoria, Australia
205.452.61001 Boehringer Ingelheim Investigational Site
Frankston, Victoria, Australia
Australia, Western Australia
205.452.61005 Boehringer Ingelheim Investigational Site
Nedlands, Western Australia, Australia
Austria
205.452.43002 Boehringer Ingelheim Investigational Site
Feldbach, Austria
205.452.43003 Boehringer Ingelheim Investigational Site
Hallein, Austria
205.452.43005 Boehringer Ingelheim Investigational Site
Thalheim bei Wels, Austria
Belgium
205.452.32009 Boehringer Ingelheim Investigational Site
Godinne, Belgium
205.452.32007 Boehringer Ingelheim Investigational Site
Gozée, Belgium
205.452.32002 Boehringer Ingelheim Investigational Site
Halen, Belgium
205.452.32001 Boehringer Ingelheim Investigational Site
Leuven, Belgium
205.452.32006 Boehringer Ingelheim Investigational Site
Linkebeek, Belgium
205.452.32005 Boehringer Ingelheim Investigational Site
Merksem, Belgium
205.452.32008 Boehringer Ingelheim Investigational Site
Natoye, Belgium
205.452.32003 Boehringer Ingelheim Investigational Site
Tessenderlo, Belgium
205.452.32004 Boehringer Ingelheim Investigational Site
Zichem, Belgium
Brazil
205.452.55005 Boehringer Ingelheim Investigational Site
Florianópolis, Brazil
205.452.55010 Boehringer Ingelheim Investigational Site
Passo Fundo - RS, Brazil
205.452.55001 Boehringer Ingelheim Investigational Site
Porto Alegre, Brazil
205.452.55002 Boehringer Ingelheim Investigational Site
Porto Alegre, Brazil
205.452.55003 Boehringer Ingelheim Investigational Site
Recife, Brazil
205.452.55004 Boehringer Ingelheim Investigational Site
Rio de Janeiro, Brazil
205.452.55011 Boehringer Ingelheim Investigational Site
Río de Janeiro, Brazil
205.452.55008 Boehringer Ingelheim Investigational Site
Sao Pablo, Brazil
205.452.55009 Boehringer Ingelheim Investigational Site
Sao Paulo, Brazil
205.452.55007 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
205.452.55006 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
Bulgaria
205.452.35910 Boehringer Ingelheim Investigational Site
Plovdiv, Bulgaria
205.452.35909 Boehringer Ingelheim Investigational Site
Plovdiv, Bulgaria
205.452.35901 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35915 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35908 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35904 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35902 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35914 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35903 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35905 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
205.452.35912 Boehringer Ingelheim Investigational Site
Stara Zagora, Bulgaria
205.452.35906 Boehringer Ingelheim Investigational Site
Veliko Turnovo, Bulgaria
Canada, Alberta
205.452.11015 Boehringer Ingelheim Investigational Site
Calgary, Alberta, Canada
205.452.11032 Boehringer Ingelheim Investigational Site
Calgary, Alberta, Canada
205.452.11047 Boehringer Ingelheim Investigational Site
Edmonton, Alberta, Canada
205.452.11028 Boehringer Ingelheim Investigational Site
Edmonton, Alberta, Canada
205.452.11045 Boehringer Ingelheim Investigational Site
Edmonton, Alberta, Canada
205.452.11037 Boehringer Ingelheim Investigational Site
Edmonton, Alberta, Canada
205.452.11002 Boehringer Ingelheim Investigational Site
Spruce Grove, Alberta, Canada
Canada, British Columbia
205.452.11048 Boehringer Ingelheim Investigational Site
Kelowna, British Columbia, Canada
205.452.11051 Boehringer Ingelheim Investigational Site
Maple Ridge, British Columbia, Canada
205.452.11014 Boehringer Ingelheim Investigational Site
Vancouver, British Columbia, Canada
205.452.11016 Boehringer Ingelheim Investigational Site
Vancouver, British Columbia, Canada
Canada, Manitoba
205.452.11025 Boehringer Ingelheim Investigational Site
Winnipeg, Manitoba, Canada
Canada, New Brunswick
205.452.11033 Boehringer Ingelheim Investigational Site
Moncton, New Brunswick, Canada
205.452.11010 Boehringer Ingelheim Investigational Site
Saint John, New Brunswick, Canada
Canada, Newfoundland and Labrador
205.452.11044 Boehringer Ingelheim Investigational Site
Grand Falls-Windsor, Newfoundland and Labrador, Canada
205.452.11053 Boehringer Ingelheim Investigational Site
Mount Pearl, Newfoundland and Labrador, Canada
205.452.11017 Boehringer Ingelheim Investigational Site
St. John's, Newfoundland and Labrador, Canada
205.452.11021 Boehringer Ingelheim Investigational Site
St. John's, Newfoundland and Labrador, Canada
Canada, Ontario
205.452.11030 Boehringer Ingelheim Investigational Site
Burlington, Ontario, Canada
205.452.11042 Boehringer Ingelheim Investigational Site
Corunna, Ontario, Canada
205.452.11049 Boehringer Ingelheim Investigational Site
Courtice, Ontario, Canada
205.452.11004 Boehringer Ingelheim Investigational Site
Downsview, Ontario, Canada
205.452.11050 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
205.452.11009 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
205.452.11029 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
205.452.11040 Boehringer Ingelheim Investigational Site
Kingston, Ontario, Canada
205.452.11035 Boehringer Ingelheim Investigational Site
London, Ontario, Canada
205.452.11001 Boehringer Ingelheim Investigational Site
Mississauga, Ontario, Canada
205.452.11054 Boehringer Ingelheim Investigational Site
Mississauga, Ontario, Canada
205.452.11022 Boehringer Ingelheim Investigational Site
Newmarket, Ontario, Canada
205.452.11024 Boehringer Ingelheim Investigational Site
Ottawa, Ontario, Canada
205.452.11027 Boehringer Ingelheim Investigational Site
Richmond Hill, Ontario, Canada
205.452.11041 Boehringer Ingelheim Investigational Site
Sarnia, Ontario, Canada
205.452.11019 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
205.452.11034 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
205.452.11052 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
205.452.11012 Boehringer Ingelheim Investigational Site
Windsor, Ontario, Canada
Canada, Quebec
205.452.11007 Boehringer Ingelheim Investigational Site
Greenfield Park, Quebec, Canada
205.452.11005 Boehringer Ingelheim Investigational Site
La Malbaie, Quebec, Canada
205.452.11006 Boehringer Ingelheim Investigational Site
Longueuil, Quebec, Canada
205.452.11043 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
205.452.11013 Boehringer Ingelheim Investigational Site
Point Claire, Quebec, Canada
205.452.11018 Boehringer Ingelheim Investigational Site
Sherbrooke, Quebec, Canada
205.452.11020 Boehringer Ingelheim Investigational Site
St. Lambert, Quebec, Canada
205.452.11026 Boehringer Ingelheim Investigational Site
Trois-Rivieres, Quebec, Canada
Canada, Saskatchewan
205.452.11036 Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
205.452.11003 Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
205.452.11011 Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
205.452.11039 Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
Canada
205.452.11031 Boehringer Ingelheim Investigational Site
Quebec, Canada
China
205.452.86038 Boehringer Ingelheim Investigational Site
Beijing, China
205.452.86012 Boehringer Ingelheim Investigational Site
Beijing, China
205.452.86010 Boehringer Ingelheim Investigational Site
Beijing, China
205.452.86009 Boehringer Ingelheim Investigational Site
Beijing, China
205.452.86011 Boehringer Ingelheim Investigational Site
Beijing, China
205.452.86026 Boehringer Ingelheim Investigational Site
Changchun, China
205.452.86024 Boehringer Ingelheim Investigational Site
Changsha, China
205.452.86025 Boehringer Ingelheim Investigational Site
Changsha, China
205.452.86021 Boehringer Ingelheim Investigational Site
Chengdu, China
205.452.86032 Boehringer Ingelheim Investigational Site
Chengdu, China
205.452.86036 Boehringer Ingelheim Investigational Site
Chongqing, China
205.452.86034 Boehringer Ingelheim Investigational Site
Chongqing, China
205.452.86035 Boehringer Ingelheim Investigational Site
Chongqing, China
205.452.86020 Boehringer Ingelheim Investigational Site
Foshan, China
205.452.86004 Boehringer Ingelheim Investigational Site
Guangzhou, China
205.452.86005 Boehringer Ingelheim Investigational Site
Guangzhou, China
205.452.86028 Boehringer Ingelheim Investigational Site
Guangzhou, China
205.452.86001 Boehringer Ingelheim Investigational Site
Guangzhou, China
205.452.86019 Boehringer Ingelheim Investigational Site
Guangzhou, China
205.452.86030 Boehringer Ingelheim Investigational Site
Haikou, China
205.452.86007 Boehringer Ingelheim Investigational Site
Hangzhou, China
205.452.86008 Boehringer Ingelheim Investigational Site
Hangzhou, China
205.452.86029 Boehringer Ingelheim Investigational Site
Nan Ning, China
205.452.86037 Boehringer Ingelheim Investigational Site
Nanchang, China
205.452.86022 Boehringer Ingelheim Investigational Site
Nanjing, China
205.452.86027 Boehringer Ingelheim Investigational Site
Qingdao, China
205.452.86003 Boehringer Ingelheim Investigational Site
Shanghai, China
205.452.86018 Boehringer Ingelheim Investigational Site
Shanghai, China
205.452.86002 Boehringer Ingelheim Investigational Site
Shanghai, China
205.452.86015 Boehringer Ingelheim Investigational Site
Shenyang, China
205.452.86014 Boehringer Ingelheim Investigational Site
Shenyang, China
205.452.86006 Boehringer Ingelheim Investigational Site
Suzhou, China
205.452.86033 Boehringer Ingelheim Investigational Site
Tianjin, China
205.452.86031 Boehringer Ingelheim Investigational Site
Wuhan, China
205.452.86017 Boehringer Ingelheim Investigational Site
Xi'An, China
205.452.86016 Boehringer Ingelheim Investigational Site
Xi'An, China
Colombia
205.452.57004 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
205.452.57006 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
205.452.57002 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
205.452.57005 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
205.452.57001 Boehringer Ingelheim Investigational Site
Medellín, Colombia
Croatia
205.452.38512 Boehringer Ingelheim Investigational Site
Cakovec, Croatia
205.452.38508 Boehringer Ingelheim Investigational Site
Dubrovnik, Croatia
205.452.38510 Boehringer Ingelheim Investigational Site
Osijek, Croatia
205.452.38501 Boehringer Ingelheim Investigational Site
Rijeka, Croatia
205.452.38506 Boehringer Ingelheim Investigational Site
Sisak, Croatia
205.452.38503 Boehringer Ingelheim Investigational Site
Split, Croatia
205.452.38502 Boehringer Ingelheim Investigational Site
Split, Croatia
205.452.38504 Boehringer Ingelheim Investigational Site
Zagreb, Croatia
205.452.38505 Boehringer Ingelheim Investigational Site
Zagreb, Croatia
205.452.38507 Boehringer Ingelheim Investigational Site
Zagreb, Croatia
205.452.38509 Boehringer Ingelheim Investigational Site
Zagreb, Croatia
205.452.38511 Boehringer Ingelheim Investigational Site
Zagreb, Croatia
Denmark
205.452.45002 Boehringer Ingelheim Investigational Site
Aalborg, Denmark
205.452.45003 Boehringer Ingelheim Investigational Site
Aarhus C, Denmark
205.452.45006 Boehringer Ingelheim Investigational Site
Birkerød, Denmark
205.452.45013 Boehringer Ingelheim Investigational Site
Kolding, Denmark
205.452.45001 Boehringer Ingelheim Investigational Site
København NV, Denmark
205.452.45005 Boehringer Ingelheim Investigational Site
København S, Denmark
205.452.45012 Boehringer Ingelheim Investigational Site
Odense C, Denmark
205.452.45016 Boehringer Ingelheim Investigational Site
Roskilde, Denmark
205.452.45010 Boehringer Ingelheim Investigational Site
Rødovre, Denmark
205.452.45009 Boehringer Ingelheim Investigational Site
Rødovre, Denmark
205.452.45004 Boehringer Ingelheim Investigational Site
Silkeborg, Denmark
205.452.45014 Boehringer Ingelheim Investigational Site
Skive, Denmark
205.452.45011 Boehringer Ingelheim Investigational Site
Sønderborg, Denmark
205.452.45015 Boehringer Ingelheim Investigational Site
Viby, Denmark
205.452.45007 Boehringer Ingelheim Investigational Site
Værløse, Denmark
Finland
205.452.35801 Boehringer Ingelheim Investigational Site
Helsinki, Finland
205.452.35804 Boehringer Ingelheim Investigational Site
Lahti, Finland
205.452.35808 Boehringer Ingelheim Investigational Site
Pori, Finland
205.452.35805 Boehringer Ingelheim Investigational Site
Porvoo, Finland
205.452.35806 Boehringer Ingelheim Investigational Site
Tammisaari, Finland
205.452.35802 Boehringer Ingelheim Investigational Site
Tampere, Finland
205.452.35803 Boehringer Ingelheim Investigational Site
Turku, Finland
France
205.452.33087 Boehringer Ingelheim Investigational Site
Albens, France
205.452.33159 Boehringer Ingelheim Investigational Site
Angers, France
205.452.33142 Boehringer Ingelheim Investigational Site
Angers, France
205.452.33055 Boehringer Ingelheim Investigational Site
Angers, France
205.452.33028 Boehringer Ingelheim Investigational Site
Angers, France
205.452.33030 Boehringer Ingelheim Investigational Site
Anzin, France
205.452.33158 Boehringer Ingelheim Investigational Site
Arras, France
205.452.33084 Boehringer Ingelheim Investigational Site
Avrillé, France
205.452.33128 Boehringer Ingelheim Investigational Site
Becon les Granits, France
205.452.33029 Boehringer Ingelheim Investigational Site
Bersée, France
205.452.33018 Boehringer Ingelheim Investigational Site
Beziers, France
205.452.33053 Boehringer Ingelheim Investigational Site
Bischheim, France
205.452.33024 Boehringer Ingelheim Investigational Site
Blois, France
205.452.33043 Boehringer Ingelheim Investigational Site
Bort les Orgues, France
205.452.33091 Boehringer Ingelheim Investigational Site
Bourg des cptes, France
205.452.33123 Boehringer Ingelheim Investigational Site
Briollay, France
205.452.33063 Boehringer Ingelheim Investigational Site
Broglie, France
205.452.33074 Boehringer Ingelheim Investigational Site
Bruay La Buissiere, France
205.452.33118 Boehringer Ingelheim Investigational Site
Cannes, France
205.452.33010 Boehringer Ingelheim Investigational Site
Cannes Cedex, France
205.452.33009 Boehringer Ingelheim Investigational Site
Chamalières, France
205.452.33073 Boehringer Ingelheim Investigational Site
Chambery, France
205.452.33059 Boehringer Ingelheim Investigational Site
Chateau Renault, France
205.452.33089 Boehringer Ingelheim Investigational Site
Colombey les Belles, France
205.452.33099 Boehringer Ingelheim Investigational Site
Cournonterral, France
205.452.33127 Boehringer Ingelheim Investigational Site
Cournonterral, France
205.452.33162 Boehringer Ingelheim Investigational Site
Croix, France
205.452.33105 Boehringer Ingelheim Investigational Site
Dinard, France
205.452.33110 Boehringer Ingelheim Investigational Site
Donges, France
205.452.33094 Boehringer Ingelheim Investigational Site
Gambsheim, France
205.452.33046 Boehringer Ingelheim Investigational Site
Grenoble, France
205.452.33096 Boehringer Ingelheim Investigational Site
Hautmont, France
205.452.33090 Boehringer Ingelheim Investigational Site
Hinx, France
205.452.33145 Boehringer Ingelheim Investigational Site
Jarny, France
205.452.33154 Boehringer Ingelheim Investigational Site
La Bouëxière, France
205.452.33065 Boehringer Ingelheim Investigational Site
La Chapelle sur Erdre, France
205.452.33102 Boehringer Ingelheim Investigational Site
La Montagne, France
205.452.33100 Boehringer Ingelheim Investigational Site
La Riche, France
205.452.33098 Boehringer Ingelheim Investigational Site
Lambersart, France
205.452.33058 Boehringer Ingelheim Investigational Site
Lambersart, France
205.452.33103 Boehringer Ingelheim Investigational Site
Levallois Perret, France
205.452.33164 Boehringer Ingelheim Investigational Site
Louvigne De bais, France
205.452.33111 Boehringer Ingelheim Investigational Site
Luynes, France
205.452.33136 Boehringer Ingelheim Investigational Site
Marcq en Baroeul, France
205.452.33115 Boehringer Ingelheim Investigational Site
Mondelange, France
205.452.33088 Boehringer Ingelheim Investigational Site
Mont de Marsan, France
205.452.33138 Boehringer Ingelheim Investigational Site
Mont de Marsan, France
205.452.33005 Boehringer Ingelheim Investigational Site
Montigny les Metz, France
205.452.33163 Boehringer Ingelheim Investigational Site
Mundolsheim, France
205.452.33109 Boehringer Ingelheim Investigational Site
Murs Erigne, France
205.452.33031 Boehringer Ingelheim Investigational Site
Nantes, France
205.452.33003 Boehringer Ingelheim Investigational Site
Nice, France
205.452.33108 Boehringer Ingelheim Investigational Site
Oignies, France
205.452.33014 Boehringer Ingelheim Investigational Site
Ollioules, France
205.452.33157 Boehringer Ingelheim Investigational Site
Orthez, France
205.452.33112 Boehringer Ingelheim Investigational Site
Parcay les Pins, France
205.452.33165 Boehringer Ingelheim Investigational Site
Paris, France
205.452.33082 Boehringer Ingelheim Investigational Site
Paris, France
205.452.33001 Boehringer Ingelheim Investigational Site
Paris, France
205.452.33051 Boehringer Ingelheim Investigational Site
Paris, France
205.452.33130 Boehringer Ingelheim Investigational Site
Pont à Mousson, France
205.452.33122 Boehringer Ingelheim Investigational Site
Quarouble, France
205.452.33006 Boehringer Ingelheim Investigational Site
Reims, France
205.452.33153 Boehringer Ingelheim Investigational Site
Rosiers d'Egletons, France
205.452.33161 Boehringer Ingelheim Investigational Site
Rugles, France
205.452.33126 Boehringer Ingelheim Investigational Site
Saint Alban Leysse, France
205.452.33140 Boehringer Ingelheim Investigational Site
Saint Aulaire, France
205.452.33052 Boehringer Ingelheim Investigational Site
Saint Avertin, France
205.452.33011 Boehringer Ingelheim Investigational Site
Saint Léger des Bois, France
205.452.33002 Boehringer Ingelheim Investigational Site
Saintes, France
205.452.33148 Boehringer Ingelheim Investigational Site
Salies de Bearn, France
205.452.33026 Boehringer Ingelheim Investigational Site
Savonnières, France
205.452.33067 Boehringer Ingelheim Investigational Site
Segre, France
205.452.33040 Boehringer Ingelheim Investigational Site
Serres Casset, France
205.452.33012 Boehringer Ingelheim Investigational Site
Six Four les Plages, France
205.452.33160 Boehringer Ingelheim Investigational Site
St Jouan des Guerets, France
205.452.33079 Boehringer Ingelheim Investigational Site
St Sebastien sur Loire, France
205.452.33033 Boehringer Ingelheim Investigational Site
Strasbourg, France
205.452.33007 Boehringer Ingelheim Investigational Site
Strasbourg, France
205.452.33101 Boehringer Ingelheim Investigational Site
Strasbourg, France
205.452.33097 Boehringer Ingelheim Investigational Site
Strasbourg, France
205.452.33107 Boehringer Ingelheim Investigational Site
Thouars, France
205.452.33116 Boehringer Ingelheim Investigational Site
Tinténiac, France
205.452.33013 Boehringer Ingelheim Investigational Site
Toulon, France
205.452.33064 Boehringer Ingelheim Investigational Site
Tours, France
205.452.33054 Boehringer Ingelheim Investigational Site
Tours, France
205.452.33124 Boehringer Ingelheim Investigational Site
Tours, France
205.452.33092 Boehringer Ingelheim Investigational Site
Tours, France
205.452.33066 Boehringer Ingelheim Investigational Site
Vendôme, France
205.452.33137 Boehringer Ingelheim Investigational Site
Vernoil, France
205.452.33032 Boehringer Ingelheim Investigational Site
Vieux Condé, France
205.452.33151 Boehringer Ingelheim Investigational Site
Vihiers, France
205.452.33077 Boehringer Ingelheim Investigational Site
Villey St Etienne, France
205.452.33135 Boehringer Ingelheim Investigational Site
Wattrelos, France
Georgia
205.452.99507 Boehringer Ingelheim Investigational Site
Tbilisi, Georgia
205.452.99506 Boehringer Ingelheim Investigational Site
Tbilisi, Georgia
205.452.99501 Boehringer Ingelheim Investigational Site
Tbilisi, Georgia
205.452.99502 Boehringer Ingelheim Investigational Site
Tbilisi, Georgia
205.452.99503 Boehringer Ingelheim Investigational Site
Tbilisi, Georgia
205.452.99504 Boehringer Ingelheim Investigational Site
Tbilisi, Georgia
205.452.99505 Boehringer Ingelheim Investigational Site
Tbilisi, Georgia
Germany
205.452.49096 Boehringer Ingelheim Investigational Site
Aschaffenburg, Germany
205.452.49161 Boehringer Ingelheim Investigational Site
Augsburg, Germany
205.452.49130 Boehringer Ingelheim Investigational Site
Augsburg, Germany
205.452.49001 Boehringer Ingelheim Investigational Site
Backnang, Germany
205.452.49173 Boehringer Ingelheim Investigational Site
Bad Kissingen, Germany
205.452.49134 Boehringer Ingelheim Investigational Site
Bad Lippspringe, Germany
205.452.49082 Boehringer Ingelheim Investigational Site
Bad Neustadt, Germany
205.452.49058 Boehringer Ingelheim Investigational Site
Bad Wörishofen, Germany
205.452.49145 Boehringer Ingelheim Investigational Site
Bamberg, Germany
205.452.49072 Boehringer Ingelheim Investigational Site
Bensheim, Germany
205.452.49048 Boehringer Ingelheim Investigational Site
Bergisch Gladbach, Germany
205.452.49016 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49175 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49006 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49066 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49135 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49138 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49064 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49180 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49167 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49102 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49157 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49068 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49054 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49031 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49028 Boehringer Ingelheim Investigational Site
Berlin, Germany
205.452.49118 Boehringer Ingelheim Investigational Site
Bonn, Germany
205.452.49037 Boehringer Ingelheim Investigational Site
Bonn, Germany
205.452.49083 Boehringer Ingelheim Investigational Site
Brake, Germany
205.452.49040 Boehringer Ingelheim Investigational Site
Bruchsal, Germany
205.452.49089 Boehringer Ingelheim Investigational Site
Celle, Germany
205.452.49143 Boehringer Ingelheim Investigational Site
Cottbus, Germany
205.452.49119 Boehringer Ingelheim Investigational Site
Deggendorf, Germany
205.452.49151 Boehringer Ingelheim Investigational Site
Dillingen, Germany
205.452.49117 Boehringer Ingelheim Investigational Site
Donaueschingen, Germany
205.452.49015 Boehringer Ingelheim Investigational Site
Dortmund, Germany
205.452.49008 Boehringer Ingelheim Investigational Site
Düren, Germany
205.452.49098 Boehringer Ingelheim Investigational Site
Emden, Germany
205.452.49003 Boehringer Ingelheim Investigational Site
Engelskirchen, Germany
205.452.49024 Boehringer Ingelheim Investigational Site
Ense, Germany
205.452.49168 Boehringer Ingelheim Investigational Site
Essen, Germany
205.452.49104 Boehringer Ingelheim Investigational Site
Forchheim, Germany
205.452.49070 Boehringer Ingelheim Investigational Site
Frankfurt, Germany
205.452.49147 Boehringer Ingelheim Investigational Site
Frankfurt, Germany
205.452.49137 Boehringer Ingelheim Investigational Site
Fulda, Germany
205.452.49133 Boehringer Ingelheim Investigational Site
Föhren, Germany
205.452.49107 Boehringer Ingelheim Investigational Site
Gelnhausen, Germany
205.452.49032 Boehringer Ingelheim Investigational Site
Gütersloh, Germany
205.452.49026 Boehringer Ingelheim Investigational Site
Hagen, Germany
205.452.49041 Boehringer Ingelheim Investigational Site
Hagen, Germany
205.452.49044 Boehringer Ingelheim Investigational Site
Hamburg, Germany
205.452.49080 Boehringer Ingelheim Investigational Site
Hamburg, Germany
205.452.49061 Boehringer Ingelheim Investigational Site
Hamburg, Germany
205.452.49052 Boehringer Ingelheim Investigational Site
Hannover, Germany
205.452.49094 Boehringer Ingelheim Investigational Site
Hannover, Germany
205.452.49038 Boehringer Ingelheim Investigational Site
Hannover, Germany
205.452.49181 Boehringer Ingelheim Investigational Site
Heidelberg, Germany
205.452.49116 Boehringer Ingelheim Investigational Site
Heilbronn, Germany
205.452.49022 Boehringer Ingelheim Investigational Site
Hemmingen, Germany
205.452.49007 Boehringer Ingelheim Investigational Site
Höchstädt, Germany
205.452.49136 Boehringer Ingelheim Investigational Site
Ingelheim, Germany
205.452.49159 Boehringer Ingelheim Investigational Site
Karlsruhe, Germany
205.452.49027 Boehringer Ingelheim Investigational Site
Kassel, Germany
205.452.49105 Boehringer Ingelheim Investigational Site
Kaufbeuren, Germany
205.452.49101 Boehringer Ingelheim Investigational Site
Koblenz, Germany
205.452.49047 Boehringer Ingelheim Investigational Site
Käbschütztal-Krögis, Germany
205.452.49146 Boehringer Ingelheim Investigational Site
Köln, Germany
205.452.49114 Boehringer Ingelheim Investigational Site
Landsberg am Lech, Germany
205.452.49169 Boehringer Ingelheim Investigational Site
Langen, Germany
205.452.49172 Boehringer Ingelheim Investigational Site
Leipzig, Germany
205.452.49035 Boehringer Ingelheim Investigational Site
Leipzig, Germany
205.452.49017 Boehringer Ingelheim Investigational Site
Leipzig, Germany
205.452.49113 Boehringer Ingelheim Investigational Site
Leipzig, Germany
205.452.49139 Boehringer Ingelheim Investigational Site
Leipzig, Germany
205.452.49110 Boehringer Ingelheim Investigational Site
Leonberg, Germany
205.452.49088 Boehringer Ingelheim Investigational Site
Mannheim, Germany
205.452.49108 Boehringer Ingelheim Investigational Site
Marburg, Germany
205.452.49122 Boehringer Ingelheim Investigational Site
Marburg, Germany
205.452.49055 Boehringer Ingelheim Investigational Site
Minden, Germany
205.452.49131 Boehringer Ingelheim Investigational Site
München, Germany
205.452.49025 Boehringer Ingelheim Investigational Site
München, Germany
205.452.49023 Boehringer Ingelheim Investigational Site
Neumünster, Germany
205.452.49132 Boehringer Ingelheim Investigational Site
Neuruppin, Germany
205.452.49045 Boehringer Ingelheim Investigational Site
Neuwied, Germany
205.452.49062 Boehringer Ingelheim Investigational Site
Oranienburg, Germany
205.452.49124 Boehringer Ingelheim Investigational Site
Oschersleben, Germany
205.452.49019 Boehringer Ingelheim Investigational Site
Paderborn, Germany
205.452.49076 Boehringer Ingelheim Investigational Site
Potsdam, Germany
205.452.49053 Boehringer Ingelheim Investigational Site
Potsdam, Germany
205.452.49049 Boehringer Ingelheim Investigational Site
Radebeul, Germany
205.452.49056 Boehringer Ingelheim Investigational Site
Rathenow, Germany
205.452.49009 Boehringer Ingelheim Investigational Site
Raubach, Germany
205.452.49002 Boehringer Ingelheim Investigational Site
Rehau, Germany
205.452.49142 Boehringer Ingelheim Investigational Site
Reinfeld, Germany
205.452.49030 Boehringer Ingelheim Investigational Site
Rhaunen, Germany
205.452.49184 Boehringer Ingelheim Investigational Site
Rheine, Germany
205.452.49077 Boehringer Ingelheim Investigational Site
Rodgau-Dudenhofen, Germany
205.452.49021 Boehringer Ingelheim Investigational Site
Rüsselsheim, Germany
205.452.49091 Boehringer Ingelheim Investigational Site
Rüsselsheim, Germany
205.452.49042 Boehringer Ingelheim Investigational Site
Saarlouis, Germany
205.452.49034 Boehringer Ingelheim Investigational Site
Schwetzingen, Germany
205.452.49057 Boehringer Ingelheim Investigational Site
Solingen, Germany
205.452.49013 Boehringer Ingelheim Investigational Site
Solingen, Germany
205.452.49078 Boehringer Ingelheim Investigational Site
Tübingen, Germany
205.452.49099 Boehringer Ingelheim Investigational Site
Ulm, Germany
205.452.49043 Boehringer Ingelheim Investigational Site
Wallerfing, Germany
205.452.49067 Boehringer Ingelheim Investigational Site
Wardenburg, Germany
205.452.49165 Boehringer Ingelheim Investigational Site
Warendorf, Germany
205.452.49051 Boehringer Ingelheim Investigational Site
Weinheim, Germany
205.452.49127 Boehringer Ingelheim Investigational Site
Weyhe, Germany
205.452.49092 Boehringer Ingelheim Investigational Site
Wiesloch, Germany
205.452.49029 Boehringer Ingelheim Investigational Site
Witten, Germany
205.452.49018 Boehringer Ingelheim Investigational Site
Witten, Germany
205.452.49095 Boehringer Ingelheim Investigational Site
Wolfsburg, Germany
205.452.49060 Boehringer Ingelheim Investigational Site
Zerbst, Germany
Greece
205.452.30002 Boehringer Ingelheim Investigational Site
Athens, Greece
205.452.30008 Boehringer Ingelheim Investigational Site
Athens, Greece
205.452.30003 Boehringer Ingelheim Investigational Site
Athens, Greece
205.452.30001 Boehringer Ingelheim Investigational Site
Heraklion, Greece
205.452.30007 Boehringer Ingelheim Investigational Site
Kalamaria, Greece
205.452.30010 Boehringer Ingelheim Investigational Site
Kavala, Greece
205.452.30012 Boehringer Ingelheim Investigational Site
Lamia, Greece
205.452.30005 Boehringer Ingelheim Investigational Site
Nafplio, Greece
205.452.30011 Boehringer Ingelheim Investigational Site
Rethymno, Greece
205.452.30006 Boehringer Ingelheim Investigational Site
Serres, Greece
205.452.30004 Boehringer Ingelheim Investigational Site
Thessaloniki, Greece
205.452.30009 Boehringer Ingelheim Investigational Site
Thessaloniki, Greece
Guatemala
205.452.50206 Boehringer Ingelheim Investigational Site
Guatemala, Guatemala
205.452.50205 Boehringer Ingelheim Investigational Site
Guatemala, Guatemala
205.452.50203 Boehringer Ingelheim Investigational Site
Nivel 12, Guatemala
205.452.50202 Boehringer Ingelheim Investigational Site
Nivel Guatemala, Guatemala
205.452.50201 Boehringer Ingelheim Investigational Site
Nivel Guatemala, Guatemala
205.452.50204 Boehringer Ingelheim Investigational Site
Nivel Guatemala, Guatemala
205.452.50207 Boehringer Ingelheim Investigational Site
Quetzaltenango, Guatemala
Hungary
205.452.36005 Boehringer Ingelheim Investigational Site
Baja, Hungary
205.452.36030 Boehringer Ingelheim Investigational Site
Budapest, Hungary
205.452.36004 Boehringer Ingelheim Investigational Site
Budapest, Hungary
205.452.36016 Boehringer Ingelheim Investigational Site
Budapest, Hungary
205.452.36007 Boehringer Ingelheim Investigational Site
Debrecen, Hungary
205.452.36013 Boehringer Ingelheim Investigational Site
Debrecen, Hungary
205.452.36015 Boehringer Ingelheim Investigational Site
Debrecen, Hungary
205.452.36029 Boehringer Ingelheim Investigational Site
Deszk, Hungary
205.452.36026 Boehringer Ingelheim Investigational Site
Dombovar, Hungary
205.452.36003 Boehringer Ingelheim Investigational Site
Erd, Hungary
205.452.36008 Boehringer Ingelheim Investigational Site
Farkasgyepü, Hungary
205.452.36020 Boehringer Ingelheim Investigational Site
Györ, Hungary
205.452.36012 Boehringer Ingelheim Investigational Site
Hajduböszörmeny, Hungary
205.452.36023 Boehringer Ingelheim Investigational Site
Hodmezovasarhely, Hungary
205.452.36010 Boehringer Ingelheim Investigational Site
Kaposvar, Hungary
205.452.36018 Boehringer Ingelheim Investigational Site
Kapuvar, Hungary
205.452.36002 Boehringer Ingelheim Investigational Site
Kecskemet, Hungary
205.452.36001 Boehringer Ingelheim Investigational Site
Makó, Hungary
205.452.36006 Boehringer Ingelheim Investigational Site
Mohacs, Hungary
205.452.36022 Boehringer Ingelheim Investigational Site
Mosonmagyarovar, Hungary
205.452.36027 Boehringer Ingelheim Investigational Site
Nagykanizsa, Hungary
205.452.36014 Boehringer Ingelheim Investigational Site
Nyiregyhaza, Hungary
205.452.36009 Boehringer Ingelheim Investigational Site
Pecs, Hungary
205.452.36011 Boehringer Ingelheim Investigational Site
Pecs, Hungary
205.452.36028 Boehringer Ingelheim Investigational Site
Siófok, Hungary
205.452.36021 Boehringer Ingelheim Investigational Site
Szarvas, Hungary
205.452.36017 Boehringer Ingelheim Investigational Site
Szeged, Hungary
205.452.36024 Boehringer Ingelheim Investigational Site
Tatabanya, Hungary
205.452.36019 Boehringer Ingelheim Investigational Site
Törökbálint, Hungary
205.452.36025 Boehringer Ingelheim Investigational Site
Törökbálint, Hungary
India
205.452.91017 Boehringer Ingelheim Investigational Site
Ahmedabad, India
205.452.91018 Boehringer Ingelheim Investigational Site
Chennai, India
205.452.91001 Boehringer Ingelheim Investigational Site
Coimbatore, India
205.452.91002 Boehringer Ingelheim Investigational Site
Coimbatore, India
205.452.91014 Boehringer Ingelheim Investigational Site
Dadar(East), India
205.452.91005 Boehringer Ingelheim Investigational Site
Hyderabad, India
205.452.91009 Boehringer Ingelheim Investigational Site
Hyderabad, India
205.452.91004 Boehringer Ingelheim Investigational Site
Jaipur, India
205.452.91007 Boehringer Ingelheim Investigational Site
Jaipur, India
205.452.91015 Boehringer Ingelheim Investigational Site
Jaipur, India
205.452.91016 Boehringer Ingelheim Investigational Site
Jaipur, India
205.452.91008 Boehringer Ingelheim Investigational Site
Karnataka, India
205.452.91006 Boehringer Ingelheim Investigational Site
Maharashtra, India
205.452.91003 Boehringer Ingelheim Investigational Site
Maharastra, India
205.452.91011 Boehringer Ingelheim Investigational Site
Punjab, India
Ireland
205.452.35307 Boehringer Ingelheim Investigational Site
Co. Cork, Ireland
205.452.35306 Boehringer Ingelheim Investigational Site
Co. Tipperary, Ireland
205.452.35305 Boehringer Ingelheim Investigational Site
Co. Wexford, Ireland
205.452.35302 Boehringer Ingelheim Investigational Site
Dublin, Ireland
205.452.35301 Boehringer Ingelheim Investigational Site
Dublin 24, Ireland
205.452.35303 Boehringer Ingelheim Investigational Site
Limerick, Ireland
205.452.35308 Boehringer Ingelheim Investigational Site
Limerick, Ireland
205.452.35304 Boehringer Ingelheim Investigational Site
Offaly, Ireland
Israel
205.452.97207 Boehringer Ingelheim Investigational Site
Ashkelon, Israel
205.452.97204 Boehringer Ingelheim Investigational Site
Beer Sheva, Israel
205.452.97208 Boehringer Ingelheim Investigational Site
Haifa, Israel
205.452.97202 Boehringer Ingelheim Investigational Site
Jerusalem, Israel
205.452.97206 Boehringer Ingelheim Investigational Site
Kfar Saba, Israel
205.452.97203 Boehringer Ingelheim Investigational Site
Petach Tikva, Israel
205.452.97201 Boehringer Ingelheim Investigational Site
Rehovot, Israel
205.452.97205 Boehringer Ingelheim Investigational Site
Tel-Aviv, Israel
Italy
205.452.39003 Boehringer Ingelheim Investigational Site
Arenzano (ge), Italy
205.452.39019 Boehringer Ingelheim Investigational Site
Ascoli Piceno, Italy
205.452.39016 Boehringer Ingelheim Investigational Site
Avellino, Italy
205.452.39007 Boehringer Ingelheim Investigational Site
Benevento, Italy
205.452.39024 Boehringer Ingelheim Investigational Site
Brescia, Italy
205.452.39029 Boehringer Ingelheim Investigational Site
Busto Arsizio (va), Italy
205.452.39020 Boehringer Ingelheim Investigational Site
Cagliari, Italy
205.452.39011 Boehringer Ingelheim Investigational Site
Cagliari, Italy
205.452.39013 Boehringer Ingelheim Investigational Site
Cagliari, Italy
205.452.39015 Boehringer Ingelheim Investigational Site
Catanzaro, Italy
205.452.39006 Boehringer Ingelheim Investigational Site
Chieti Scalo, Italy
205.452.39001 Boehringer Ingelheim Investigational Site
Firenze, Italy
205.452.39021 Boehringer Ingelheim Investigational Site
Monza, Italy
205.452.39014 Boehringer Ingelheim Investigational Site
Napoli, Italy
205.452.39026 Boehringer Ingelheim Investigational Site
Orbassano (to), Italy
205.452.39012 Boehringer Ingelheim Investigational Site
Orbassano (to), Italy
205.452.39010 Boehringer Ingelheim Investigational Site
Palermo, Italy
205.452.39005 Boehringer Ingelheim Investigational Site
Parma, Italy
205.452.39009 Boehringer Ingelheim Investigational Site
Perugia, Italy
205.452.39002 Boehringer Ingelheim Investigational Site
Prato, Italy
205.452.39030 Boehringer Ingelheim Investigational Site
Reggio Emilia, Italy
205.452.39004 Boehringer Ingelheim Investigational Site
Roma, Italy
205.452.39017 Boehringer Ingelheim Investigational Site
Roma, Italy
205.452.39027 Boehringer Ingelheim Investigational Site
Roma, Italy
205.452.39023 Boehringer Ingelheim Investigational Site
Treviso, Italy
Korea, Republic of
205.452.82008 Boehringer Ingelheim Investigational Site
Bucheon, Korea, Republic of
205.452.82012 Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
205.452.82002 Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
205.452.82010 Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
205.452.82016 Boehringer Ingelheim Investigational Site
Daejoen, Korea, Republic of
205.452.82009 Boehringer Ingelheim Investigational Site
Gangwon-Do, Korea, Republic of
205.452.82017 Boehringer Ingelheim Investigational Site
Goyang, Korea, Republic of
205.452.82004 Boehringer Ingelheim Investigational Site
Gwangju, Korea, Republic of
205.452.82005 Boehringer Ingelheim Investigational Site
Incheon, Korea, Republic of
205.452.82020 Boehringer Ingelheim Investigational Site
Jeonju, Korea, Republic of
205.452.82014 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82007 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82006 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82003 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82013 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82011 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82015 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82018 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82001 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
205.452.82019 Boehringer Ingelheim Investigational Site
Uijeongbu, Korea, Republic of
Latvia
205.452.37107 Boehringer Ingelheim Investigational Site
Daugavpils, Latvia
205.452.37108 Boehringer Ingelheim Investigational Site
Daugavpils, Latvia
205.452.37106 Boehringer Ingelheim Investigational Site
Daugavpils, Latvia
205.452.37102 Boehringer Ingelheim Investigational Site
Kraslava, Latvia
205.452.37109 Boehringer Ingelheim Investigational Site
Riga, Latvia
205.452.37104 Boehringer Ingelheim Investigational Site
Riga, Latvia
205.452.37105 Boehringer Ingelheim Investigational Site
Riga, Latvia
205.452.37110 Boehringer Ingelheim Investigational Site
Riga, Latvia
205.452.37101 Boehringer Ingelheim Investigational Site
Talsi, Latvia
205.452.37103 Boehringer Ingelheim Investigational Site
Valmiera, Latvia
Lithuania
205.452.37003 Boehringer Ingelheim Investigational Site
Alytus, Lithuania
205.452.37001 Boehringer Ingelheim Investigational Site
Kaunas, Lithuania
205.452.37002 Boehringer Ingelheim Investigational Site
Kaunas, Lithuania
205.452.37005 Boehringer Ingelheim Investigational Site
Klaipeda, Lithuania
205.452.37007 Boehringer Ingelheim Investigational Site
Siauliai, Lithuania
205.452.37011 Boehringer Ingelheim Investigational Site
Utena, Lithuania
205.452.37010 Boehringer Ingelheim Investigational Site
Vilnius, Lithuania
205.452.37004 Boehringer Ingelheim Investigational Site
Vilnius, Lithuania
205.452.37008 Boehringer Ingelheim Investigational Site
Vilnius, Lithuania
Malaysia
205.452.60006 Boehringer Ingelheim Investigational Site
Johor Bahru, Malaysia
205.452.60004 Boehringer Ingelheim Investigational Site
Kuala Lumpur, Malaysia
205.452.60001 Boehringer Ingelheim Investigational Site
Kuala Lumpur, Malaysia
205.452.60002 Boehringer Ingelheim Investigational Site
Kuala Lumpur, Malaysia
205.452.60008 Boehringer Ingelheim Investigational Site
Pahang, Malaysia
205.452.60005 Boehringer Ingelheim Investigational Site
Sarawak, Malaysia
205.452.60009 Boehringer Ingelheim Investigational Site
Selangor, Malaysia
205.452.60007 Boehringer Ingelheim Investigational Site
Terengganu, Malaysia
Mexico
205.452.52004 Boehringer Ingelheim Investigational Site
Aguascalientes, Mexico
205.452.52007 Boehringer Ingelheim Investigational Site
Distrito Federal, Mexico
205.452.52005 Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
205.452.52002 Boehringer Ingelheim Investigational Site
Monte Rey, Mexico
205.452.52001 Boehringer Ingelheim Investigational Site
México, Mexico
205.452.52003 Boehringer Ingelheim Investigational Site
Zona Río, Mexico
Netherlands
205.452.31001 Boehringer Ingelheim Investigational Site
Almere, Netherlands
205.452.31008 Boehringer Ingelheim Investigational Site
Andijk, Netherlands
205.452.31002 Boehringer Ingelheim Investigational Site
Beek, Netherlands
205.452.31012 Boehringer Ingelheim Investigational Site
Beek En Donk, Netherlands
205.452.31003 Boehringer Ingelheim Investigational Site
Ermelo, Netherlands
205.452.31010 Boehringer Ingelheim Investigational Site
Hoogwoud, Netherlands
205.452.31011 Boehringer Ingelheim Investigational Site
Nijverdal, Netherlands
205.452.31007 Boehringer Ingelheim Investigational Site
Oude Pekela, Netherlands
205.452.31005 Boehringer Ingelheim Investigational Site
Roelofarendsveen, Netherlands
New Zealand
205.452.64004 Boehringer Ingelheim Investigational Site
Christchurch, New Zealand
205.452.64003 Boehringer Ingelheim Investigational Site
Dunedin, New Zealand
205.452.64002 Boehringer Ingelheim Investigational Site
Newtown Wellington NZ, New Zealand
205.452.64001 Boehringer Ingelheim Investigational Site
Tauranga, New Zealand
Norway
205.452.47008 Boehringer Ingelheim Investigational Site
Drammen, Norway
205.452.47009 Boehringer Ingelheim Investigational Site
Fredrikstad, Norway
205.452.47001 Boehringer Ingelheim Investigational Site
Hønefoss, Norway
205.452.47010 Boehringer Ingelheim Investigational Site
Kløfta, Norway
205.452.47007 Boehringer Ingelheim Investigational Site
Kolbjørnsvik, Norway
205.452.47005 Boehringer Ingelheim Investigational Site
Løvenstad, Norway
205.452.47011 Boehringer Ingelheim Investigational Site
Oslo, Norway
205.452.47003 Boehringer Ingelheim Investigational Site
Oslo, Norway
205.452.47002 Boehringer Ingelheim Investigational Site
Oslo, Norway
205.452.47012 Boehringer Ingelheim Investigational Site
Sandvika, Norway
205.452.47004 Boehringer Ingelheim Investigational Site
Svelvik, Norway
205.452.47006 Boehringer Ingelheim Investigational Site
Trollåsen, Norway
Panama
205.452.50703 Boehringer Ingelheim Investigational Site
Carrasquilla, Panama
205.452.50702 Boehringer Ingelheim Investigational Site
Marbella, Panama
205.452.50701 Boehringer Ingelheim Investigational Site
Marbella, Panama
Peru
205.452.51002 Boehringer Ingelheim Investigational Site
Bellavista, Peru
205.452.51003 Boehringer Ingelheim Investigational Site
Cusco, Peru
205.452.51004 Boehringer Ingelheim Investigational Site
Jesús Maria, Peru
205.452.51007 Boehringer Ingelheim Investigational Site
Jesús María, Peru
205.452.51005 Boehringer Ingelheim Investigational Site
Lima, Peru
205.452.51001 Boehringer Ingelheim Investigational Site
San Isidro, Peru
205.452.51006 Boehringer Ingelheim Investigational Site
San Martin de Porres, Peru
Philippines
205.452.63004 Boehringer Ingelheim Investigational Site
Cavite City, Philippines
205.452.63002 Boehringer Ingelheim Investigational Site
Davao City, Philippines
205.452.63003 Boehringer Ingelheim Investigational Site
Iloilo City, Philippines
205.452.63006 Boehringer Ingelheim Investigational Site
Iloilo City, Philippines
205.452.63001 Boehringer Ingelheim Investigational Site
Manila, Philippines
205.452.63008 Boehringer Ingelheim Investigational Site
Manila, Philippines
205.452.63005 Boehringer Ingelheim Investigational Site
Quezon City, Philippines
205.452.63007 Boehringer Ingelheim Investigational Site
Quezon City, Philippines
Poland
205.452.48031 Boehringer Ingelheim Investigational Site
Babice, Poland
205.452.48003 Boehringer Ingelheim Investigational Site
Bialystok, Poland
205.452.48011 Boehringer Ingelheim Investigational Site
Bialystok, Poland
205.452.48014 Boehringer Ingelheim Investigational Site
Bydgoszcz, Poland
205.452.48008 Boehringer Ingelheim Investigational Site
Checiny, Poland
205.452.48016 Boehringer Ingelheim Investigational Site
Gdansk, Poland
205.452.48019 Boehringer Ingelheim Investigational Site
Gdynia, Poland
205.452.48037 Boehringer Ingelheim Investigational Site
Gorzow Wlkp, Poland
205.452.48015 Boehringer Ingelheim Investigational Site
Ilawa, Poland
205.452.48044 Boehringer Ingelheim Investigational Site
Katowice, Poland
205.452.48039 Boehringer Ingelheim Investigational Site
Katowice, Poland
205.452.48033 Boehringer Ingelheim Investigational Site
Katowice, Poland
205.452.48029 Boehringer Ingelheim Investigational Site
Krakow, Poland
205.452.48021 Boehringer Ingelheim Investigational Site
Krakow, Poland
205.452.48048 Boehringer Ingelheim Investigational Site
Krakow, Poland
205.452.48009 Boehringer Ingelheim Investigational Site
Krakow, Poland
205.452.48030 Boehringer Ingelheim Investigational Site
Krakow, Poland
205.452.48043 Boehringer Ingelheim Investigational Site
Libiaz, Poland
205.452.48056 Boehringer Ingelheim Investigational Site
Lodz, Poland
205.452.48051 Boehringer Ingelheim Investigational Site
Lodz, Poland
205.452.48002 Boehringer Ingelheim Investigational Site
Lodz, Poland
205.452.48059 Boehringer Ingelheim Investigational Site
Lodz, Poland
205.452.48018 Boehringer Ingelheim Investigational Site
Olsztyn, Poland
205.452.48025 Boehringer Ingelheim Investigational Site
Ostrow Wielkopolska, Poland
205.452.48012 Boehringer Ingelheim Investigational Site
Piaseczno, Poland
205.452.48040 Boehringer Ingelheim Investigational Site
Piaseczno, Poland
205.452.48058 Boehringer Ingelheim Investigational Site
Poznan, Poland
205.452.48027 Boehringer Ingelheim Investigational Site
Poznan, Poland
205.452.48026 Boehringer Ingelheim Investigational Site
Poznan, Poland
205.452.48060 Boehringer Ingelheim Investigational Site
Rokietnica, Poland
205.452.48001 Boehringer Ingelheim Investigational Site
Skierniewice, Poland
205.452.48032 Boehringer Ingelheim Investigational Site
Slawkow, Poland
205.452.48036 Boehringer Ingelheim Investigational Site
Szczecin, Poland
205.452.48045 Boehringer Ingelheim Investigational Site
Tarnow, Poland
205.452.48057 Boehringer Ingelheim Investigational Site
Tczew, Poland
205.452.48004 Boehringer Ingelheim Investigational Site
Torun, Poland
205.452.48007 Boehringer Ingelheim Investigational Site
Tranow, Poland
205.452.48053 Boehringer Ingelheim Investigational Site
Turek, Poland
205.452.48034 Boehringer Ingelheim Investigational Site
Warsaw, Poland
205.452.48049 Boehringer Ingelheim Investigational Site
Warszawa, Poland
205.452.48042 Boehringer Ingelheim Investigational Site
Warszawa, Poland
205.452.48017 Boehringer Ingelheim Investigational Site
Wolomin, Poland
205.452.48038 Boehringer Ingelheim Investigational Site
Wroclaw, Poland
205.452.48035 Boehringer Ingelheim Investigational Site
Wroclaw, Poland
205.452.48028 Boehringer Ingelheim Investigational Site
Wroclaw, Poland
205.452.48006 Boehringer Ingelheim Investigational Site
Wroclaw, Poland
205.452.48022 Boehringer Ingelheim Investigational Site
Zakopane, Poland
Portugal
205.452.35103 Boehringer Ingelheim Investigational Site
Amadora, Portugal
205.452.35102 Boehringer Ingelheim Investigational Site
Coimbra, Portugal
205.452.35108 Boehringer Ingelheim Investigational Site
Lisboa, Portugal
205.452.35107 Boehringer Ingelheim Investigational Site
Lisboa, Portugal
205.452.35101 Boehringer Ingelheim Investigational Site
Matosinhos, Portugal
205.452.35105 Boehringer Ingelheim Investigational Site
Penafiel, Portugal
205.452.35106 Boehringer Ingelheim Investigational Site
Vila Nova de Gaia, Portugal
205.452.35104 Boehringer Ingelheim Investigational Site
Viseu, Portugal
Puerto Rico
205.452.01177 Boehringer Ingelheim Investigational Site
Ponce, Puerto Rico
205.452.01162 Boehringer Ingelheim Investigational Site
San Juan, Puerto Rico
Romania
205.452.40012 Boehringer Ingelheim Investigational Site
Brasov, Romania
205.452.40008 Boehringer Ingelheim Investigational Site
Brasov, Romania
205.452.40003 Boehringer Ingelheim Investigational Site
Bucharest, Romania
205.452.40004 Boehringer Ingelheim Investigational Site
Bucharest, Romania
205.452.40007 Boehringer Ingelheim Investigational Site
Bucharest, Romania
205.452.40001 Boehringer Ingelheim Investigational Site
Bucharest, Romania
205.452.40013 Boehringer Ingelheim Investigational Site
Bucharest, Romania
205.452.40009 Boehringer Ingelheim Investigational Site
Bucharest, Romania
205.452.40002 Boehringer Ingelheim Investigational Site
Bucuresti, Romania
205.452.40011 Boehringer Ingelheim Investigational Site
Constanta, Romania
205.452.40006 Boehringer Ingelheim Investigational Site
Craiova, Romania
Russian Federation
205.452.07030 Boehringer Ingelheim Investigational Site
Arkhangelsk, Russian Federation
205.452.07054 Boehringer Ingelheim Investigational Site
Barnaul, Russian Federation
205.452.07049 Boehringer Ingelheim Investigational Site
Barnaul, Russian Federation
205.452.07053 Boehringer Ingelheim Investigational Site
Chelyabinsk, Russian Federation
205.452.07031 Boehringer Ingelheim Investigational Site
Ekaterinburg, Russian Federation
205.452.07038 Boehringer Ingelheim Investigational Site
Gatchina (Leningradskaya oblast), Russian Federation
205.452.07036 Boehringer Ingelheim Investigational Site
Irkutsk, Russian Federation
205.452.07001 Boehringer Ingelheim Investigational Site
Ivanovo, Russian Federation
205.452.07023 Boehringer Ingelheim Investigational Site
Kaliningrad, Russian Federation
205.452.07003 Boehringer Ingelheim Investigational Site
Kazan, Russian Federation
205.452.07005 Boehringer Ingelheim Investigational Site
Kazan, Russian Federation
205.452.07007 Boehringer Ingelheim Investigational Site
Kazan, Russian Federation
205.452.07060 Boehringer Ingelheim Investigational Site
Kemerovo, Russian Federation
205.452.07048 Boehringer Ingelheim Investigational Site
Kemerovo, Russian Federation
205.452.07059 Boehringer Ingelheim Investigational Site
Kirov, Russian Federation
205.452.07009 Boehringer Ingelheim Investigational Site
Krasnodar, Russian Federation
205.452.07010 Boehringer Ingelheim Investigational Site
Krasnodar, Russian Federation
205.452.07020 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07021 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07029 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07045 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07043 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07026 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07027 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07028 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07013 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
205.452.07004 Boehringer Ingelheim Investigational Site
Murmansk, Russian Federation
205.452.07055 Boehringer Ingelheim Investigational Site
Nizhniy Novgorod, Russian Federation
205.452.07051 Boehringer Ingelheim Investigational Site
Nizhny Novgorod, Russian Federation
205.452.07040 Boehringer Ingelheim Investigational Site
Novosibirsk, Russian Federation
205.452.07042 Boehringer Ingelheim Investigational Site
Novosibirsk, Russian Federation
205.452.07037 Boehringer Ingelheim Investigational Site
Novosibirsk, Russian Federation
205.452.07041 Boehringer Ingelheim Investigational Site
Penza, Russian Federation
205.452.07050 Boehringer Ingelheim Investigational Site
Pskov, Russian Federation
205.452.07015 Boehringer Ingelheim Investigational Site
Rostov-na-Donu, Russian Federation
205.452.07016 Boehringer Ingelheim Investigational Site
Rostov-on-Don, Russian Federation
205.452.07039 Boehringer Ingelheim Investigational Site
Ryazan, Russian Federation
205.452.07034 Boehringer Ingelheim Investigational Site
Samara, Russian Federation
205.452.07047 Boehringer Ingelheim Investigational Site
Saratov, Russian Federation
205.452.07033 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07022 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07017 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07024 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07046 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07025 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07018 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07052 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07014 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07006 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07002 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07011 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
205.452.07032 Boehringer Ingelheim Investigational Site
Tomsk, Russian Federation
205.452.07035 Boehringer Ingelheim Investigational Site
Tomsk, Russian Federation
205.452.07057 Boehringer Ingelheim Investigational Site
Tomsk, Russian Federation
205.452.07019 Boehringer Ingelheim Investigational Site
Velikiy Novgorod, Russian Federation
205.452.07044 Boehringer Ingelheim Investigational Site
Yaroslavl, Russian Federation
Serbia
205.452.38107 Boehringer Ingelheim Investigational Site
Belgrade, Serbia
205.452.38106 Boehringer Ingelheim Investigational Site
Belgrade, Serbia
205.452.38103 Boehringer Ingelheim Investigational Site
Belgrade, Serbia
205.452.38104 Boehringer Ingelheim Investigational Site
Belgrade, Serbia
205.452.38102 Boehringer Ingelheim Investigational Site
Kragujevac, Serbia
205.452.38105 Boehringer Ingelheim Investigational Site
Nis, Serbia
205.452.38101 Boehringer Ingelheim Investigational Site
Sremska Kamenica, Serbia
Slovakia
205.452.42103 Boehringer Ingelheim Investigational Site
Bardejov, Slovakia
205.452.42107 Boehringer Ingelheim Investigational Site
Bratislava, Slovakia
205.452.42102 Boehringer Ingelheim Investigational Site
Humenne, Slovakia
205.452.42111 Boehringer Ingelheim Investigational Site
Kosice, Slovakia
205.452.42105 Boehringer Ingelheim Investigational Site
Kosice, Slovakia
205.452.42113 Boehringer Ingelheim Investigational Site
Kosice, Slovakia
205.452.42108 Boehringer Ingelheim Investigational Site
Levice, Slovakia
205.452.42109 Boehringer Ingelheim Investigational Site
Martin, Slovakia
205.452.42112 Boehringer Ingelheim Investigational Site
Poprad, Slovakia
205.452.42101 Boehringer Ingelheim Investigational Site
Presov, Slovakia
205.452.42104 Boehringer Ingelheim Investigational Site
Rimavska Sobota, Slovakia
205.452.42106 Boehringer Ingelheim Investigational Site
Spisska Nova Ves, Slovakia
205.452.42110 Boehringer Ingelheim Investigational Site
Sturovo, Slovakia
South Africa
205.452.27013 Boehringer Ingelheim Investigational Site
Amanzimtoti, South Africa
205.452.27002 Boehringer Ingelheim Investigational Site
Bellville, South Africa
205.452.27010 Boehringer Ingelheim Investigational Site
Bloemfontein, South Africa
205.452.27004 Boehringer Ingelheim Investigational Site
Cape Town, South Africa
205.452.27011 Boehringer Ingelheim Investigational Site
Cape Town, South Africa
205.452.27008 Boehringer Ingelheim Investigational Site
Cape Town, South Africa
205.452.27012 Boehringer Ingelheim Investigational Site
Cape Town, South Africa
205.452.27001 Boehringer Ingelheim Investigational Site
Cape Town, South Africa
205.452.27006 Boehringer Ingelheim Investigational Site
Centurion, South Africa
205.452.27003 Boehringer Ingelheim Investigational Site
Durban, South Africa
205.452.27014 Boehringer Ingelheim Investigational Site
Johannesburg, South Africa
205.452.27009 Boehringer Ingelheim Investigational Site
Pretoria, South Africa
205.452.27005 Boehringer Ingelheim Investigational Site
Pretoria, South Africa
205.452.27007 Boehringer Ingelheim Investigational Site
Somerset West, South Africa
Spain
205.452.34018 Boehringer Ingelheim Investigational Site
Badajoz, Spain
205.452.34021 Boehringer Ingelheim Investigational Site
Badalona (Barcelona), Spain
205.452.34010 Boehringer Ingelheim Investigational Site
Barcelona, Spain
205.452.34025 Boehringer Ingelheim Investigational Site
Barcelona, Spain
205.452.34027 Boehringer Ingelheim Investigational Site
Centelles, Spain
205.452.34015 Boehringer Ingelheim Investigational Site
Cáceres, Spain
205.452.34016 Boehringer Ingelheim Investigational Site
Elda, Spain
205.452.34008 Boehringer Ingelheim Investigational Site
Hospitalet de Llobregat, Spain
205.452.34026 Boehringer Ingelheim Investigational Site
Lugo, Spain
205.452.34011 Boehringer Ingelheim Investigational Site
Madrid, Spain
205.452.34019 Boehringer Ingelheim Investigational Site
Madrid, Spain
205.452.34020 Boehringer Ingelheim Investigational Site
Málaga, Spain
205.452.34002 Boehringer Ingelheim Investigational Site
Mérida, Spain
205.452.34017 Boehringer Ingelheim Investigational Site
Plasencia, Spain
205.452.34001 Boehringer Ingelheim Investigational Site
Pozuelo de Alarcón, Spain
205.452.34024 Boehringer Ingelheim Investigational Site
San Juan de Alicante, Spain
205.452.34003 Boehringer Ingelheim Investigational Site
Santander, Spain
205.452.34005 Boehringer Ingelheim Investigational Site
Terrassa (Barcelona), Spain
205.452.34007 Boehringer Ingelheim Investigational Site
Torrevieja, Spain
205.452.34012 Boehringer Ingelheim Investigational Site
Valencia, Spain
205.452.34013 Boehringer Ingelheim Investigational Site
Valladolid, Spain
205.452.34009 Boehringer Ingelheim Investigational Site
Vic (Barcelona), Spain
205.452.34023 Boehringer Ingelheim Investigational Site
Vilanova i la Geltrú, Spain
205.452.34004 Boehringer Ingelheim Investigational Site
Zaragoza, Spain
Sweden
205.452.46005 Boehringer Ingelheim Investigational Site
Brämhult, Sweden
205.452.46014 Boehringer Ingelheim Investigational Site
Eksjö, Sweden
205.452.46012 Boehringer Ingelheim Investigational Site
Gullspång, Sweden
205.452.46013 Boehringer Ingelheim Investigational Site
Göteborg, Sweden
205.452.46001 Boehringer Ingelheim Investigational Site
Höllviken, Sweden
205.452.46008 Boehringer Ingelheim Investigational Site
Järfälla, Sweden
205.452.46009 Boehringer Ingelheim Investigational Site
Kil, Sweden
205.452.46007 Boehringer Ingelheim Investigational Site
Lidingö, Sweden
205.452.46003 Boehringer Ingelheim Investigational Site
Luleå, Sweden
205.452.46010 Boehringer Ingelheim Investigational Site
Sigtuna, Sweden
205.452.46002 Boehringer Ingelheim Investigational Site
Solna, Sweden
205.452.46011 Boehringer Ingelheim Investigational Site
Uddevalla, Sweden
205.452.46006 Boehringer Ingelheim Investigational Site
Örebro, Sweden
Switzerland
205.452.41003 Boehringer Ingelheim Investigational Site
Ascona, Switzerland
205.452.41004 Boehringer Ingelheim Investigational Site
Basel, Switzerland
205.452.41016 Boehringer Ingelheim Investigational Site
Bern, Switzerland
205.452.41012 Boehringer Ingelheim Investigational Site
Glarus, Switzerland
205.452.41001 Boehringer Ingelheim Investigational Site
Gossau, Switzerland
205.452.41015 Boehringer Ingelheim Investigational Site
Liestal, Switzerland
205.452.41010 Boehringer Ingelheim Investigational Site
Locarno, Switzerland
205.452.41011 Boehringer Ingelheim Investigational Site
Lugano, Switzerland
205.452.41007 Boehringer Ingelheim Investigational Site
Spiez, Switzerland
205.452.41009 Boehringer Ingelheim Investigational Site
St. Gallen, Switzerland
205.452.41002 Boehringer Ingelheim Investigational Site
St. Gallen, Switzerland
205.452.41013 Boehringer Ingelheim Investigational Site
Zürich, Switzerland
205.452.41014 Boehringer Ingelheim Investigational Site
Zürich, Switzerland
Taiwan
205.452.88607 Boehringer Ingelheim Investigational Site
Changhua, Taiwan
205.452.88614 Boehringer Ingelheim Investigational Site
Chia-Yi, Taiwan
205.452.88611 Boehringer Ingelheim Investigational Site
Kaohsiung, Taiwan
205.452.88609 Boehringer Ingelheim Investigational Site
Kaohsiung City, Taiwan
205.452.88608 Boehringer Ingelheim Investigational Site
Kaohsiung City, Taiwan
205.452.88604 Boehringer Ingelheim Investigational Site
New Taipei, Taiwan
205.452.88605 Boehringer Ingelheim Investigational Site
Taichung, Taiwan
205.452.88612 Boehringer Ingelheim Investigational Site
Taichung, Taiwan
205.452.88606 Boehringer Ingelheim Investigational Site
Taichung, Taiwan
205.452.88610 Boehringer Ingelheim Investigational Site
Tainan, Taiwan
205.452.88603 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
205.452.88613 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
205.452.88602 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
205.452.88601 Boehringer Ingelheim Investigational Site
Taoyuan County, Taiwan
Thailand
205.452.66004 Boehringer Ingelheim Investigational Site
Chiang Mai, Thailand
205.452.66003 Boehringer Ingelheim Investigational Site
Hatyai, Songkhla, Thailand
205.452.66002 Boehringer Ingelheim Investigational Site
Khon Kaen, Thailand
205.452.66005 Boehringer Ingelheim Investigational Site
Muang, Phitsanulok, Thailand
205.452.66001 Boehringer Ingelheim Investigational Site
Nonthaburi, Thailand
Tunisia
205.452.21603 Boehringer Ingelheim Investigational Site
Ariana, Tunisia
205.452.21606 Boehringer Ingelheim Investigational Site
Ariana, Tunisia
205.452.21607 Boehringer Ingelheim Investigational Site
Ariana, Tunisia
205.452.21605 Boehringer Ingelheim Investigational Site
Ariana, Tunisia
205.452.21610 Boehringer Ingelheim Investigational Site
Mahdia, Tunisia
205.452.21609 Boehringer Ingelheim Investigational Site
Monastir, Tunisia
205.452.21608 Boehringer Ingelheim Investigational Site
Nabeul, Tunisia
205.452.21602 Boehringer Ingelheim Investigational Site
Tunis, Tunisia
205.452.21604 Boehringer Ingelheim Investigational Site
Tunis, Tunisia
205.452.21601 Boehringer Ingelheim Investigational Site
Tunis, Tunisia
Turkey
205.452.90001 Boehringer Ingelheim Investigational Site
Adana, Turkey
205.452.90008 Boehringer Ingelheim Investigational Site
Ankara, Turkey
205.452.90013 Boehringer Ingelheim Investigational Site
Ankara, Turkey
205.452.90005 Boehringer Ingelheim Investigational Site
Antalya, Turkey
205.452.90018 Boehringer Ingelheim Investigational Site
Aydin, Turkey
205.452.90003 Boehringer Ingelheim Investigational Site
Bolu, Turkey
205.452.90006 Boehringer Ingelheim Investigational Site
Edirne, Turkey
205.452.90010 Boehringer Ingelheim Investigational Site
Erzurum, Turkey
205.452.90019 Boehringer Ingelheim Investigational Site
Hatay, Turkey
205.452.90017 Boehringer Ingelheim Investigational Site
Istanbul, Turkey
205.452.90021 Boehringer Ingelheim Investigational Site
Istanbul, Turkey
205.452.90020 Boehringer Ingelheim Investigational Site
Istanbul, Turkey
205.452.90016 Boehringer Ingelheim Investigational Site
Izmir, Turkey
205.452.90022 Boehringer Ingelheim Investigational Site
Izmir, Turkey
205.452.90015 Boehringer Ingelheim Investigational Site
Izmir, Turkey
205.452.90007 Boehringer Ingelheim Investigational Site
Malatya, Turkey
Ukraine
205.452.38028 Boehringer Ingelheim Investigational Site
Crimea, Ukraine
205.452.38024 Boehringer Ingelheim Investigational Site
Dnipropetrovks, Ukraine
205.452.38022 Boehringer Ingelheim Investigational Site
Dnipropetrovsk, Ukraine
205.452.38034 Boehringer Ingelheim Investigational Site
Dnyepropyetrovsk, Ukraine
205.452.38020 Boehringer Ingelheim Investigational Site
Donetsk, Ukraine
205.452.38002 Boehringer Ingelheim Investigational Site
Donetsk, Ukraine
205.452.38011 Boehringer Ingelheim Investigational Site
Ivano-Frankivsk, Ukraine
205.452.38005 Boehringer Ingelheim Investigational Site
Kharkiv, Ukraine
205.452.38008 Boehringer Ingelheim Investigational Site
Kharkov, Ukraine
205.452.38018 Boehringer Ingelheim Investigational Site
Kharkov, Ukraine
205.452.38006 Boehringer Ingelheim Investigational Site
Kharkov, Ukraine
205.452.38001 Boehringer Ingelheim Investigational Site
Kharkov, Ukraine
205.452.38004 Boehringer Ingelheim Investigational Site
Kharkov, Ukraine
205.452.38012 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
205.452.38013 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
205.452.38010 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
205.452.38003 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
205.452.38032 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
205.452.38015 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
205.452.38026 Boehringer Ingelheim Investigational Site
Nikolayev, Ukraine
205.452.38023 Boehringer Ingelheim Investigational Site
Odesa, Ukraine
205.452.38031 Boehringer Ingelheim Investigational Site
Odessa, Ukraine
205.452.38027 Boehringer Ingelheim Investigational Site
Odessa, Ukraine
205.452.38017 Boehringer Ingelheim Investigational Site
Simferopol, Ukraine
205.452.38019 Boehringer Ingelheim Investigational Site
Vinnytsya, Ukraine
205.452.38030 Boehringer Ingelheim Investigational Site
Zaporizhzhya, Ukraine
United Kingdom
205.452.44010 Boehringer Ingelheim Investigational Site
Atherstone, United Kingdom
205.452.44008 Boehringer Ingelheim Investigational Site
Burbage, United Kingdom
205.452.44004 Boehringer Ingelheim Investigational Site
Chertsey, United Kingdom
205.452.44002 Boehringer Ingelheim Investigational Site
Chesterfield, United Kingdom
205.452.44003 Boehringer Ingelheim Investigational Site
Coventry, United Kingdom
205.452.44001 Boehringer Ingelheim Investigational Site
Exeter, United Kingdom
205.452.44007 Boehringer Ingelheim Investigational Site
Fowey, United Kingdom
205.452.44005 Boehringer Ingelheim Investigational Site
Frome, United Kingdom
205.452.44011 Boehringer Ingelheim Investigational Site
Leamington Spa, United Kingdom
205.452.44006 Boehringer Ingelheim Investigational Site
St Just, Penzance, United Kingdom
Sponsors and Collaborators
Boehringer Ingelheim
Investigators
Study Chair: Boehringer Ingelheim Boehringer Ingelheim
  More Information

Additional Information:
No publications provided by Boehringer Ingelheim

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Boehringer Ingelheim
ClinicalTrials.gov Identifier: NCT01126437     History of Changes
Other Study ID Numbers: 205.452, 2009-015713-51
Study First Received: May 6, 2010
Results First Received: May 20, 2014
Last Updated: May 20, 2014
Health Authority: Argentina: Admin Nacional de Medicamentos, Alimentos Tecnologia Medica
Australia: Dept of Health and Ageing Therapeutic Goods Admin
Austria: Medicines and Medical Devices Agency
Belgium: Federal Agency for Medicinal and Health Products
Brazil: National Health Surveillance Agency
Bulgaria: Bulgarian Drug Agency
Canada: Health Canada
China: Food and Drug Administration
Columbia: Instituto Nacional de Vigilancia de Medicamentos y Alimentos
Croatia: Agency for Medicinal Product and Medical Devices
Denmark: Danish Medicines Agency
Finland: Finnish Medicines Agency
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Georgia: Ministry of Health
Germany: Federal Institute for Drugs and Medical Devices
Greece: Ethics Committee
Guatemala: Ministry of Public Health and Social Assistance
Hungary: National Institute of Pharmacy
India: Drugs Controller General of India
Ireland: Irish Medicines Board
Israel: Israeli Health Ministry Pharmaceutical Administration
Italy: Ethics Committee
Latvia: State Agency of Medicines
Lithuania: State Medicine Control Agency - Ministry of Health
Malaysia: Ministry of Health
Mexico: Federal Commission for Sanitary Risks Protection
Netherlands: Central Committee Research Involving Human Subjects
New Zealand: Multi-Regional Ethics Committee
Norway: Norwegian Medicines Agency
Panama: Ministry of Health
Peru: General Directorate of Pharmaceuticals, Devices, and Drugs
Philippines: Bureau of Food and Drugs
Poland: Registration Medicinal Product Medical Device Biocidal Product
Portugal: National Pharmacy and Medicines Institute
Romania: National Medicines Agency
Russia: Pharmacological Committee, Ministry of Health
Serbia and Montenegro: Agency for Drugs and Medicinal Devices
Slovakia: State Institute for Drug Control
South Africa: Medicines Control Council
South Korea: Ministry of Food and Drug Safety (MFDS)
Spain: Spanish Agency of Medicines
Sweden: Medical Products Agency
Switzerland: Swissmedic
Taiwan: Department of Health
Thailand: Food and Drug Administration
Tunisia: Ministry of Public Health
Turkey: Ministry of Health
Ukraine: State Pharmacological Center - Ministry of Health
United Kingdom: Medicines and Healthcare Products Regulatory Agency
United States: Food and Drug Administration

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Chronic Disease
Respiratory Tract Diseases
Disease Attributes
Pathologic Processes
Tiotropium
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Anti-Asthmatic Agents
Respiratory System Agents
Therapeutic Uses
Parasympatholytics
Cholinergic Antagonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on September 18, 2014